Our invisible addicts. First report of the older persons’ substance misuse working group of the Royal College of Psychiatrists. by Crome, Ilana et al.
College Report CR165
© 2011 Royal College of Psychiatrists
 
College Reports have been approved by a meeting of the Central Executive Committee and constitute 
official College policy until they are revised or withdrawn. They are given blue covers and are numbered 
CR1, CR2, etc.
 
For full details of reports available and how to obtain them, contact the Book Sales Assistant at the Royal 
College of Psychiatrists, 17 Belgrave Square, London SW1X 8PG (tel. 020 7235 2351, fax 020 7245 1231).
 
The Royal College of Psychiatrists is a charity registered in England and Wales (228636) and in Scotland 
(SC038369).
Our invisible addicts
First Report of the Older Persons’ Substance Misuse 
Working Group of the Royal College of Psychiatrists
College Report CR165
June 2011
Royal College of Psychiatrists
London
Approved by Central Policy Coordination Committee: January 2011
Due for review: 2016
Disclaimer
 This guidance (as updated from time to time) is for use by members of the Royal College of 
Psychiatrists. It sets out guidance, principles and specific recommendations that, in the view of the 
College, should be followed by members. None the less, members remain responsible for regulating 
their own conduct in relation to the subject matter of the guidance. Accordingly, to the extent 
permitted by applicable law, the College excludes all liability of any kind arising as a consequence, 
directly or indirectly, of the member either following or failing to follow the guidance.
3Royal College of Psychiatrists
Contents
Working Group 4
Executive summary and recommendations 6
Introduction 11
Risk factors 17
Effects and complications  23
Assessment of substance misuse in older people 25
Treatment of addiction 31
Service models: implications for service development 37
Appendix 1: Assessment of substance misuse in older people 42
Appendix 2: Guidance for pharmacological treatment of 
substance problems in older people 44
Appendix 3: Model alcohol misuse services for older people 48
Appendix 4: Online resources 51
References 53
4 http://www.rcpsych.ac.uk
Working group
eDitorial Group
Professor Ilana Crome
Dr Karim Dar
Dr Stefan Janikiewicz
Dr Tony Rao
Dr Andrew Tarbuck
members of the WorkinG Group
Professor Ilana Crome 
(Chair)
Professor of Addiction Psychiatry and Academic 
Director of Psychiatry, Keele University Medical 
School; Consultant Addiction Psychiatrist, 
South Staffordshire and Shropshire Healthcare 
NHS Foundation Trust
Andrew Brown Director of Programmes, Mentor UK
Dr Karim Dar Consultant Addiction Psychiatrist, Central and 
North West London NHS Foundation Trust
Dr Linda Harris Clinical Director, Substance Misuse and 
Associated Health Unit, Royal College of 
General Practitioners
Dr Stefan Janikiewicz General Practitioner Principal; Royal College of 
General Practitioners’ North West Substance 
Misuse Co-Lead; Clinical Director, Substance 
Misuse Service, Cheshire and Wirral 
Partnership NHS Trust
Dr Tony (Rahul) Rao Consultant in Old Age Psychiatry, North 
Southwark Community Mental Health Team, 
South London and Maudsley NHS Foundation 
Trust, and Associate Dean, Royal College of 
Psychiatrists and London Deanery
Dr Don Shenker Chief Executive, Alcohol Concern
Dr Andrew Tarbuck Consultant in Old Age Psychiatry, Norfolk 
and Waveney Mental Health NHS Foundation 
Trust; Honorary Senior Lecturer, University of 
East Anglia; Director, DeNDRoN East Anglia 
(Dementias & Neurodegenerative Diseases 
Local Research Network)
5Royal College of Psychiatrists
Working group
We are indebted to Dr Michael S. Dennis (School of Medicine, Swansea 
University), Dr Michael Farrell and Dr Owen Bowden Jones (on behalf of 
the Faculty of Addictions), and Dr David Anderson and Dr Peter Connelly 
(on behalf of the Faculty of Old Age Psychiatry) for their contribution to the 
development of the report
We would like to acknowledge the excellent secretarial support of Marion 
Riley and Corrina Knight
6 http://www.rcpsych.ac.uk
Executive summary  
and recommendations
Both alcohol and illicit drugs are among the top ten risk factors for 
mortality and morbidity in Europe and substance misuse by older people 
is now a growing public health problem. Between 2001 and 2031, there is 
projected to be a 50% increase in the number of older people in the UK. The 
percentage of men and women drinking more than the weekly recommended 
limits has also risen, by 60% in men and 100% in women between 1990 and 
2006 (NHS Information Centre, 2009a). Given the likely impact of these two 
factors on health and social care services, there is now a pressing need to 
address substance misuse in older people. 
This report has brought together a group of health professionals with 
expertise in substance misuse in older people, whose remit it has been to 
develop the existing knowledge base according to the following terms of 
reference:
  examining the nature and extent of substance misuse in older people
  identifying precipitants and complications
  highlighting best-practice guidance
  exploring training opportunities
  developing future strategy, encompassing clinical service provision and 
developments, training and education, research, and policy.
nature anD extent of the problem
  The proportion of older people in the population is increasing rapidly, 
as is the number of older people with substance use problems 
  Mortality rates linked to drug and alcohol use are higher in older people 
compared with younger people
  High rates of mental health problems in older people (including a 
high prevalence of cognitive disorders) result in frequent, complex 
psychiatric comorbidity accompanying substance use disorders
  Older people may show complex patterns and combinations of 
substance use (e.g. alcohol plus inappropriate use of prescribed 
medications) 
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Executive summary and recommendations 
  Older people use large amounts of prescription and over-the-counter 
medication and rates of misuse (both intentional and inadvertent) are 
high, particularly in older women
  Although alcohol use does decline with age, a significant number of 
older people consume alcohol at dangerous levels
  Although illicit drug use is uncommon in the over-65 age group at 
present, there have already been significant increases in the over-
40 age group. As this cohort ages we should anticipate a significant 
increase in the number of older people using illicit drugs
precipitants anD complications
  Late-onset substance misuse has different aetiological and 
demographic associations, and probably a better prognosis, than early-
onset misuse
  In older people, the relationship between cognitive function and 
substance (particularly alcohol) use is complex, as is that between 
functional mental health problems (e.g. anxiety and depression) and 
substance use. The direction of causality is often unclear
  Older men are at greater risk of developing alcohol and illicit substance 
use problems than older women. However, older women have a higher 
risk of developing problems related to the misuse of prescribed and 
over-the-counter medications
  Physical health problems and the long-term prescription of medication 
(especially hypnotics, anxiolytics and analgesics) are important factors 
in the development of substance misuse in older people
  Psychiatric comorbidities of substance misuse are common in older 
people (including intoxication and delirium, withdrawal syndromes, 
anxiety, depression and cognitive changes/dementia)
  Among older people, psychosocial factors (including bereavement, 
retirement, boredom, loneliness, homelessness and depression) are 
all associated with higher rates of alcohol use
  Because of physiological changes associated with ageing, older people 
are at increased risk of adverse physical effects of substance misuse, 
even at relatively modest levels of intake
  Alcohol and tobacco use have the greatest impact in population terms 
on physical health, affecting many systems (including the cardio-
vascular, gastrointestinal, neurological and respiratory systems)
  Presentation can be subtle or non-specific and the aetiological role of 
substance use in physical conditions is frequently overlooked
best practice
  Older people with substance use problems have high levels of unmet 
need
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  General practitioners should screen every person over 65 years of age 
for substance misuse as part of a routine health check, using specific 
tools such as the Short Michigan Alcoholism Screening Test – Geriatric 
version (SMAST-G); screening should also incorporate cognitive testing 
using tools such as the Mini-Mental State Examination (MMSE)
  Re-screening should be carried out if certain physical and/or 
psychological symptoms are present or if the person is experiencing 
major life events
  Older people can and do benefit from treatment and in some cases 
have better outcomes than younger people
  Treatment of coexisting physical conditions (including chronic condi-
tions such as hepatitis C and chronic obstructive pulmonary disease) 
and psychological conditions is a very important part of management
  Although applying the standard diagnostic criteria for substance use 
disorders is useful, it should be noted that sometimes they may not be 
appropriate for older people
  Patients who repeatedly do well in hospital and badly at home, those 
with unexplained ‘ups & downs’ in health presentation, those with 
inconsistencies and contradictions in the history and presentation are 
of particular concern
  Association of substance misuse (particularly alcohol) and conditions 
such as liver disease, hypertension, diabetes, falls, cognitive problems, 
depression, self-harm, incontinence (often not a readily apparent 
association) indicates specific physical investigations
  Close liaison between all professionals, disciplines and agencies 
involved in the care of the patient is very important
  Current recommended ‘safe limits’ for alcohol consumption are based 
on work in younger adults. Because of physiological and metabolic 
changes associated with ageing, these ‘safe limits’ are too high for 
older people; recent evidence suggests that the upper ‘safe limit’ for 
older people is 1.5 units per day or 11 units per week
  In older people, binge drinking should be defined as >4.5 units in a 
single session for men and >3 units for women 
  Local policies regarding older people with substance use problems 
should be developed: access on the basis of need, elimination of age 
barriers, easy transfer between services, joint working and decisions 
regarding who will be the lead service in these circumstances, as well 
as protocols regarding admission for detoxification
traininG 
  Training about the impact of substance misuse on the older person is 
not an optional extra
  Training for all medical professionals should commence at under-
graduate level, through specialist postgraduate education and continue 
as part of continuing professional development (CPD)
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Executive summary and recommendations 
  Old age psychiatrists, addiction specialists and psychiatrists, 
geriatricians, as well as nursing, psychology, social care and other 
allied professionals should be suitably trained
  It is essential that health professionals have adequate knowledge of 
substance use disorders in older people; this includes being aware 
of associations with mental disorders and physical health problems, 
as well as vigilance over interactions between substances and both 
prescribed and over-the-counter medications 
  Clinical skills in the areas of screening, assessing motivation to change 
substance using behaviours, as well as delivering brief interventions 
and social interventions to reduce relapse within a harm reduction 
model should be core competencies for health and allied health 
professionals
  Improved attitudes to older people with substance misuse in areas 
such as addressing stigma, therapeutic nihilism and social exclusion 
are required at individual, community and public health levels
research
  Examination of trends in the extent, nature and predictors of substance 
use problems in older people is required
  Standardised age-appropriate assessment and outcome measures that 
encourage comparability should be developed
  Effective interventions for adults should be evaluated and innovative 
treatments for older people developed
  Service models with a particular focus on long-term outcome should 
be developed and evaluated
recommenDations anD future strateGic Direction
1  At a policy level, advocating for the inclusion of this issue in more 
substantive terms in all relevant policy documents. An initial step 
might be influencing policy makers to develop clinical guidelines 
through care pathways addressing the varied needs of older substance 
misusers.
2  At a public health level, developing a consensus on information for the 
public and healthcare professionals on drinking limits specifically for 
older adults and highlighting risks to health.
3  At the service delivery level, access to prevention and treatment should 
be enhanced by removing barriers, training of healthcare staff, use of 
valid screening instruments and developing closer working models – 
including innovative paradigms – between services at all levels.
4  At the treatment intervention level, exploring how to augment the 
cautious implementation of drug treatment interventions currently used 
for younger adults.
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5  At the educational level, developing comprehensive training and 
education packages in conjunction with other medical Royal Colleges 
for professionals of different backgrounds.
6  At the research and development level, improving knowledge of the 
epidemiology of substance problems in various settings and developing 
an evidence base on effective treatments and service provision barriers 
from systematic research, audit and evaluation.
7  At the ethical level, developing, implementing and promoting service 
delivery based on need, but targeted in an age-appropriate way 
through multi-agency partnership is the way forward.
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Introduction
Both alcohol and illicit drugs are among the top ten risk factors for mortality 
and morbidity in Europe (European Commission, 2006) and substance 
misuse by older people is now a growing public health problem. Between 
2001 and 2031, there is projected to be a 50% increase in the number of 
older people in the UK (Office for National Statistics, 2004). The percentage 
of men and women drinking more than the weekly recommended limits has 
also risen, by 60% in men and 100% in women between 1990 and 2006 
(NHS Information Centre, 2009a). Given the likely impact of these two 
factors on health and social care services, there is now a pressing need to 
address substance misuse in older people. 
This report has brought together a group of health professionals with 
expertise in substance misuse in older people, whose remit it has been to 
develop the existing knowledge base according to the following terms of 
reference:
  examining the nature and extent of substance misuse in older people
  identifying precipitants and complications
  highlighting best-practice guidance
  exploring training opportunities
  developing future strategy, encompassing clinical service provision and 
developments, training and education, research, and policy.
Terminology
The terms ‘drug’ or ‘substance’ will be used to cover licit substances, tobacco 
and alcohol, illicit substances, central nervous system depressants such as 
opiates and opioids (e.g. heroin and methadone), stimulants (e.g. cocaine, 
crack cocaine, amphetamines and 3,4-methylenedioxymethamphetamine, 
known as MDMA or ecstasy), lysergic acid diethylamide (LSD), khat and 
magic mushrooms. They will also be used in describing ‘street’ use, use 
of prescription drugs (e.g. benzodiazepines) in a manner not indicated or 
intended by a medical practitioner, and similar use of over-the-counter 
preparations such as codeine-based products (e.g. cough medicines, 
decongestants) or drugs bought over the internet.
Clinical experience and a growing literature base indicate that older 
people may use a combination of licit and illicit substances, as well as 
prescribed and over-the-counter medications taken in accordance with 
medical practitioners’ instructions. This so-called ‘polypharmacy’, ‘polydrug 
misuse’ or ‘polydrug dependence’ is a particular issue in older people who 
have comorbid physical and psychological problems. Patients may be offered, 
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borrow or share out-of-date medications, take foods, and/or drugs and/
or medications that interact, and store medications inappropriately. With 
increasing anxiety and poor memory, they may forget to report what they 
have taken, or simply forget that they have taken it at all. With the growing 
complexity of the range of substances available by a number of routes or 
means, this becomes a major risk faced by all medical teams (Crome & 
Ghodse, 2007; Crome & Bloor, 2008). 
For the purpose of reaching a ‘diagnosis’, the two systems that 
have emerged are the International Classification of Diseases (ICD-10) 
(World Health Organization, 1992) and the Diagnostic and Statistical 
Manual (DSM-IV) (American Psychiatric Association, 1994). These should 
be administered thoughtfully and with clinical judgement, since there is 
some debate as to whether they can be applied to older people. These 
classification systems have similarities, but are not identical. In particular, 
DSM-IV diagnostic criteria for substance ‘abuse’ and ‘dependence’ may not 
be adequate to diagnose older adults with substance use problems, as they 
are based on knowledge of young to middle-aged adults. Frequency, quantity 
and pattern of consumption, which may be more appropriate considerations 
for assessing older adults, are not included in the criteria in either ICD-10 or 
DSM-IV (Oslin & Holden, 2001). Table 1 lists considerations that should be 
taken into account in using DSM-IV with older adults.
 The prevalence of substance misuse among ‘older’ or ‘elderly’ people 
varies according to definitions of ‘old’ (usually over 65 years of age in the 
UK, but often as low as 40 in countries such as the USA) and of ‘substance 
misuse’ (Crome & Day, 1999). Nevertheless, there are considerable grounds 
for concern that there are unmet needs within communities and that 
problems are likely to increase. 
In the case of opiate misuse, people aged 40 and over are regarded 
as ‘older’ (National Treatment Agency for Substance Misuse, 2010a). This 
Table 1 Applying DSM-IV diagnostic criteria for substance dependence to older adults
Criteria Special considerations for older adults
1 Tolerance Even low intake may cause problems owing to 
physiological changes
2 Withdrawal May not develop physiological dependence
3 Taking larger amounts or over a longer 
period than was intended
Cognitive impairment can interfere with self-monitoring 
4 Unsuccessful efforts to cut down or 
control use
Reduced social pressures to decrease harmful use
5 Increased time spent obtaining 
substances or recovering from effects
Negative effects can occur with relatively low use
6 Giving up activities because of use Decreased activities because of comorbid psychiatric 
and physical disorder 
Social isolation and disability making detection more 
difficult
7 Continued use despite physical or 
psychological consequences
May not know or understand that problems are related 
to use, even after medical advice  
Failure of clinician to attribute problems to alcohol or 
drug misuse
Adapted from Blow (1998).
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Introduction
is because opiate misuse has traditionally been seen as a problem mainly 
in people under the age of 40; now that many more opiate misusers are 
surviving for longer, 40 is used as a cut-off point to define the ‘older’ 
population (Crome et al, 2009). 
epiDemioloGy
The proportion of the UK population aged 65 years and over will increase 
in the next 20 years. Projection studies have estimated that the number of 
patients over the age of 50 who will require treatment for ‘substance abuse’ 
in the USA will increase from 1.4 million in 2000–2001 to 4.4 million in 2020 
(Gfroerer et al, 2003; Colliver et al, 2006; Han et al, 2009). In 1995, 49% 
of the US ‘baby-boom’ cohort, then aged 31–49, had used illicit drugs during 
their lifetime, compared with 11% of those who were over 50 (Gfroerer et 
al, 2003). In the USA, the lifetime prevalence rates for dependence on illegal 
substances have been estimated to be 17% for 18- to 29-year-olds, 4% for 
30- to 59-year-olds and 1% for the over-60s (Crome, 2005). This picture is 
mirrored in Europe and the UK, where estimates suggest that the number 
of people over 65 with a substance use problem or needing treatment will 
more than double between 2001 and 2020 (European Monitoring Centre 
for Drugs and Drug Addiction, 2008; NHS Information Centre, 2009b; 
National Treatment Agency for Substance Misuse, 2010a). It is likely that 
the consequences of improved healthcare of substance misusers have only 
recently become apparent in the increased prevalence of chronic substance 
use problems among older people. 
morTaliTy
Smoking tobacco is the largest cause of premature death in the UK, causing 
106 000 deaths every year (Department of Health, 2006). 
Strikingly, the number of deaths in the UK linked to alcohol more 
than doubled between 1992 and 2008, from 4023 to 9031, with the highest 
death rates found in men aged 55–74. Among women, those aged 55–74 
had the highest alcohol-related death rates (Office for National Statistics, 
2009a). 
Deaths related to drug poisoning among people over the age of 40 
have also increased since 2004 (Office for National Statistics, 2009b). Cohort 
studies have demonstrated a mortality rate in drug users between 12 and 
22 times greater than that in the general population; older (over age 34) 
injecting drug users are between two and six times more likely than younger 
(under age 25) users to die from drug-related causes (Oppenheimer et al, 
1994; Frischer et al, 1997; Bird et al, 2003). 
Post-mortem findings from drug users often show a combination of 
methadone, opiates or benzodiazepines and sometimes alcohol. Although 
this association is maintained in older drug users, those aged 45 and over 
are more likely to die from self-harm or suicide, rather than accidental 
overdose (Ghodse et al, 2009). Underreporting may be associated with 
underestimation of drug-related deaths and with alcohol misuse as a 
contributing factor rarely being recorded on death certificates as a direct or 
indirect cause of death. Coroners in different areas also vary in the manner 
in which alcohol misuse is recorded on death certificates. 
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alcohol consumpTion 
Alcohol is now by far the most commonly misused drug by people of all 
ages. The price of alcohol relative to average UK income has halved since 
the 1960s, while per capita consumption of total alcohol has nearly doubled, 
from less than 6 litres a year in the early 1960s to over 11.5 litres a year in 
2000. If this trend continues, the UK will become Europe’s biggest per capita 
consumer of alcohol within a decade (Gupta & Warner, 2008). 
A substantial percentage of older adults who drink consume above the 
recommended limits (Moos et al, 2009). 
In 2008, 21% of older men reported drinking more than 4 units of 
alcohol on at least one day a week, and 7% more than 8 units; 10% of older 
women said they drank more than 3 units of alcohol on at least one day in 
the week, and 2% of this age group drank at least 6 units (NHS Information 
Centre, 2010). In comparison, in 2001, 18% of older men said they drank 
more than 4 units of alcohol on at least one day a week, and 5% drank at 
least 8 units; 5% of older women reported drinking more than 3 units of 
alcohol on at least one day in the week, and 1% of this group drank at least 
6 units (National Statistics, 2003).
Drug misuse
During 2008/2009, 4.8% of over-45-year-olds in the UK reported use of any 
illicit drug in the previous year, and 0.7% reported use of a Class A drug 
within the previous year (Hoare, 2009). Although the number of people 
coming into treatment has fallen across all other age groups, it has been 
rising for people aged 40 and over since 2005–2006 (National Treatment 
Agency for Substance Misuse 2010a: p. 6). The main problem for this age 
group is heroin, either alone or in combination with crack cocaine. Only a 
quarter started using in the past 5 years, and 27% appear to have been 
using drugs for 25 years or more. 
Consequently, there is likely to be an increased demand for specialist 
drug treatment services to cater for the needs of these patients as they age. 
This has been demonstrated in north-west England, where the proportion of 
over-45-year-olds attending services has increased from 6.4% in 2003/2004 
to 10.1% in 2006/2007 (Benyon et al, 2007). Older patients receiving 
methadone maintenance treatment are more stable and more likely to have 
improved treatment outcomes than younger people (Firoz & Carlson, 2004). 
It should be noted that older methadone clients exposed to illegal drug use 
in their social networks and neighbourhoods in the past month were more 
likely to have used illicit drugs (Rosen, 2004). 
smoking
Although people over the age of 60 have the lowest prevalence of smoking, 
13% of men and 12% of women in that age group smoke. This has reduced 
from 16% in 1998 (Seymour & Booth, 2010). Twenty-two per cent of people 
aged 50–59 still smoke, a reduction of 5% since 1998. It has been shown 
that people who are well into middle age when they quit smoking can avoid 
more than 90% of smoking-related lung cancer risk (Peto et al, 2000). 
Forty-four per cent of smokers aged 50 or over want to quit (Rimer et al, 
1990), but some older smokers think that they cannot stop or that they have 
already caused so much damage that quitting would not be beneficial to their 
health (Appel & Aldrich, 2003). 
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prescripTion Drug misuse
Older people receive the highest proportion of the prescription medication 
dispensed in the UK, often as multiple prescriptions, and there is a 10% 
chance that it is potentially inappropriate (Gottlieb, 2004; McGrath et al, 
2005; De Wilde et al, 2007). About a third of men and women over the age 
of 65 in private households take four or more prescribed medicines daily 
(Falaschetti et al, 2002). Over-the-counter availability (and different methods 
of obtaining medicines other than through legitimate channels) makes 
multiple analgesic drug use a particular problem. This may lead to poor 
pain control because of reduced tolerance, increasing dosage, abstinence 
syndrome and dependence (Chrischilles et al, 1990). This is compounded 
further by the use of prescription drugs such as codeine-based medications 
for pain or coughs and benzodiazepine tranquillisers or hypnotics for affective 
and anxiety disorders (Culberson & Ziska, 2008). Failure to adhere to 
prescribing instructions can cause a wide range of adverse effects (Balestrieri 
et al, 2005), including tolerance, withdrawal symptoms and compulsive use 
in the long term (Lingford-Hughes et al, 2004). 
The prevalence of psychotropic drug misuse is four times higher in 
older women than older men and the risk of dependence is enhanced if the 
woman happens to be widowed, less educated, of lower income, in poor 
health and/or with reduced social support (Simoni-Wastila & Yang, 2006). 
Older women also show comparatively less drinking, smoking and illicit drug 
use than older men and people under 65, regardless of gender (Graham 
et al, 1995). 
psychiaTric comorbiDiTy
One in six people presenting in primary care with substance misuse is over 
the age of 50. In the over-50 age group, presentation is often complicated 
by the increased prevalence of comorbid physical and mental illnesses. In an 
epidemiological study of psychiatric illness and comorbid substance misuse in 
primary care, a 27% increase in comorbidity occurred in those aged 75–84 
compared with an average 62% across all age groups. This increase was due 
to dependence on licit substances, i.e. benzodiazepines, and was associated 
with delirium (Frisher et al, 2005). This study demonstrates that there may 
be differences in rates of different types of comorbid condition in older 
people compared with younger people and further highlight the potentially 
deleterious cumulative effects of benzodiazepines – especially in combination 
with other substances such as alcohol. Psychiatric disorders predisposing 
to substance misuse may have been precipitated in early life by emotional, 
physical and sexual abuse.
The UK Office for National Statistics’ study of psychiatric morbidity in 
the 16–74 age group (Coulthard et al, 2002) showed decreases in lifetime 
and past-year use of any illicit drugs from age 55 to 69, but an increase in the 
70–74 age group, in keeping with Frisher et al’s (2005) data. Nine per cent of 
those in the 55–59 age group who had ever taken drugs had experienced an 
overdose, as had 5% of those over 60 who had ever taken drugs. 
An American study reported that the prevalence of comorbidity 
declined significantly with age in a population in long-term contact with 
treatment services. In the survey of patients attending the Veterans 
Administration Hospital, 26.7% of patients under 65 years of age and 6.9% 
of those aged 65 and over still had comorbid psychiatric and substance 
abuse disorders (Prigerson et al, 2001).
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key messaGes
  The proportion of older people in the population is increasing rapidly, as is the number 
of older people with substance use problems 
  Older people may show complex patterns and combinations of substance use (e.g. 
alcohol plus inappropriate use of prescribed medications)
  The standard diagnostic criteria for substance use disorders may not be applicable to 
older age groups
  Older people with substance use problems have high levels of unmet need
  Mortality rates linked to drug and alcohol use are higher in older people compared with 
younger people
  Although alcohol use does decline with age, a significant number of older people 
consume alcohol at dangerous levels
  Although illicit drug use is uncommon in the over-65 age group at present, there 
have already been significant increases in the over-40 age group. As this cohort ages 
we should anticipate a significant increase in the number of older people using illicit 
drugs
  Older people use large amounts of prescription and over-the-counter medication 
and rates of misuse (both intentional and inadvertent) are high, particularly in older 
women
  High rates of mental health problems in older people (including a high prevalence of 
cognitive disorders) result in frequent, complex psychiatric comorbidity accompanying 
substance use disorders
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Risk factors
case viGnette 1
Mr A, a 67-year-old White widower, was referred by his general practitioner (GP) 
to the community alcohol team for alcohol dependence after repeated falls. 
Following a period of controlled drinking during his 20s and early 30s, his alcohol 
use had escalated when his wife was diagnosed with post-natal depression and 
their children were taken into care. Over the years, further perpetuating factors 
included his wife’s suicide and brother’s death. He had no significant periods 
of abstinence from alcohol for over three decades. Mr A was aware of the 
association between drinking and falls, but considered alcohol helpful in dealing 
with chronic insomnia. He was under the care of psychiatric services and had 
been diagnosed with depression at the age of 36, when he had had psychological 
therapy and antidepressant medication. He had last seen a psychiatrist 10 years 
ago and had been prescribed an antidepressant by his GP before referral to the 
community alcohol team.
Mr A had regular motivational interviewing sessions with the community alcohol 
team and successfully completed in-patient detoxification. His mood improved 
considerably during his in-patient stay and he was discharged with a plan 
for follow-up by the community alcohol team, for relapse management and 
monitoring of his mood disorder. However, he disengaged from the services 
soon afterwards and was discharged from the team’s care. However, the GP re-
referred him after a few months, as family had become increasingly concerned 
about deterioration in his mood and physical health. Although he attended 
appointments at the clinic and his family was eager to admit him again for 
detoxification, he was certain that he would like to continue to drink and refused 
detoxification. He had been assessed as having capacity to make decisions 
regarding his treatment. While further motivational interviewing sessions were 
provided by the team, which he attended erratically, his mental and physical 
health deteriorated, with suicidal ideation and falls. As he refused admission or 
any intervention to address his alcohol problem and family repeatedly requested 
treatment against his will, input from the older adults psychiatric services was 
sought and a referral made. This was declined until the case was discussed 
individually with the consultant psychiatrist in the older adults team; Mr A was 
then jointly assessed at home by psychiatrists from the community alcohol team 
and older adults team. Joint work between the two teams was facilitated and he 
was later discharged to the care of older adults teams.
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case viGnette key points
  There is a recognisable association between major life events, psychiatric disorder 
and alcohol problems
  Periods of relapse may occur against a background of long-standing comorbid mental 
health problems 
  Quick and effective response to depressive symptoms can be associated with improved 
treatment outcome
  It is important to determine mental capacity of older people who are disengaging from 
services/treatment
  Joint working between specialist addiction and elderly services can have a considerable 
impact on prognosis
case viGnette key points
  Sociocultural issues have a bearing on risk, particularly the risk to Mr B’s grandchild
  Mr B’s chronic physical ailments may have masked long-standing alcohol problems 
and delayed presentation to specialist alcohol services
  Non-adherence in taking a large number of prescribed medications posed risks for 
physical health
  Joint work between specialist services led to a diagnosis of dementia, extended 
interventions and a favourable treatment outcome
case viGnette 2
Mr B is an 82-year-old Asian man living in his own home with wife, children and 
grandchild. He has chronic physical problems, which have necessitated numerous 
hospital admissions. There is a history of at least four decades of alcohol misuse. 
He lost his job in his late 50s because of his drinking. This is his first presentation 
to a specialist alcohol team, and it has come about because family can no longer 
cope with him. Risks include poor self-care, threatening his family members with a 
knife when they deny him access to alcohol, falling onto the bed of his grandchild 
when drunk, losing his way when out of the house and showing poor adherence 
to taking his 13 prescribed medications for physical illness. Following engagement 
with the community alcohol team, his care was discussed with the older adults 
team because of evidence suggestive of dementia. He was admitted to an in-
patient detoxification unit, where a diagnosis of dementia was made, and he was 
subsequently referred to a day hospital for further assessment of the dementia. 
Social Services assessment was sought both to support the carers as well as to 
assess risk to the grandchild. Mr B remained abstinent from alcohol and engaged 
with the day hospital until he was discharged 3 months later. He was supported 
in the community by a clinical nurse specialist from the community alcohol team, 
jointly working with the older adults team. Mr B’s family reported improved self-
care and no further episodes of violence or aggression; he himself identified an 
improved financial situation and improved relationship with his family, who felt 
better able to support him in adhering to treatment for his physical illness.
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alcohol misuse
The alcohol misuse literature shows that it is important to identify histories 
and effects of drinking among older people.
long-Term misuse (Drinking from an early age)
  Early-onset drinkers have had alcohol-related problems over several 
decades and have survived into old age. It is estimated that two-
thirds of older drinkers fall into this category. Various studies have 
demonstrated that, typically, this group have often been arrested 
for intoxication, have family histories of alcoholism, greater levels of 
depression and anxiety, and have changed residence more frequently. 
It has been suggested that they feel loneliness and depression after 
years of alienating significant others and age-related loss (Schonfeld 
& Dupree, 1994).
laTe-onseT misuse
  Late-onset misuse may be milder, more circumscribed, have a lower 
genetic component, a stronger association with stress/adverse life 
events (such as bereavement) and higher socioeconomic status, 
female preponderance and better prognosis. Late-onset drinkers 
usually begin drinking in their 50s or 60s. A conglomeration of different 
studies indicate that this group are more motivated to change their 
drinking habits, more likely to complete treatment and have greater 
life satisfaction. Stressful life events and losses are common in this 
group: Glatt (1978) demonstrated that 70% of late-onset drinkers had 
had stressful life events, compared with 25% of early-onset drinkers. 
However, the former had greater psychological stability and better 
attendance at treatment.
alcohol anD cogniTive impairmenT
  The relationship between alcohol use and cognitive impairment 
in older people is complex. Heavy, prolonged alcohol use may 
increase the risk of developing vascular dementia and Alzheimer’s 
disease, and may have indirect effects on neuronal function through 
decreased absorption of thiamine (vitamin B1), resulting in the 
development of organic amnestic states (e.g. Wernicke–Korsakoff 
syndrome). 
  Alcohol may also have a direct neurotoxic effect, producing 
‘alcoholic dementia’, although the validity of this concept remains 
controversial (for a discussion see Atkinson (2002) and Gupta & 
Warner (2008)). 
  Irrespective of the underlying pathophysiology, there is no doubt 
that the management of alcohol misuse in patients with cognitive 
impairment/dementia presents a significant clinical challenge.
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risk factors for substance misuse in General
Risk factors relating to substance misuse in older people can be classified 
in a number of ways, including biological/physical, psychological and social 
factors (O’Connell & Lawlor, 2008), or predisposing, precipitating and 
maintaining factors. Atkinson (2002) grouped them into predisposing factors 
(family history, previous substance misuse, personality), factors that may 
increase exposure to/consumption of substances (e.g. chronic painful illness, 
insomnia, long-term prescribing, stress, loneliness, depression, substance 
availability, finances) and factors that may increase the effects and misuse 
potential of substances (pharmacokinetic and pharmacodynamic factors, 
chronic medical conditions and use of other medication). 
A family history of alcohol or substance misuse is a risk factor 
for early-onset substance use disorders and may be related to genetic 
factors, which may in turn overlap with genetic factors predisposing to 
other psychiatric conditions. The relationship between substance use 
disorders and mental health problems such as depression and anxiety is 
complex and the direction of causality is often in doubt (e.g. does increased 
alcohol intake result from ‘self-medication’ in depression, or is the depression 
secondary to high levels of consumption?). It has been suggested that late-
onset alcohol misuse is associated with ‘neurotic’ and ‘depressive’ personality 
traits (Mulder, 2002).
In general, men are at greater risk of developing substance use 
disorders. Although this is true for both alcohol and illicit drugs in older 
people, it is older women who are at highest risk of developing problematic 
use of sedative/hypnotic and anxiolytic medication. 
Another factor relevant to the development of substance use disorders 
in older people is chronic illness that leads to the long-term prescription 
of strong analgesics and medication to manage symptoms such as pain, 
insomnia and anxiety. The presence of underlying medical conditions, 
age-related changes in liver and renal function, and interactions between 
multiple medications may also place older people at higher risk of developing 
substance-related problems, even at relatively low levels of consumption. 
Over-use of ‘as required’ medicines, either by the patient or by paid carers 
or family members, may be an additional factor. Although many older 
people live in relative poverty, a substantial number of retired people have 
significant disposable income and leisure time, which can contribute to the 
development of alcohol problems.
Loss of support over the long term owing to loss of occupation, income, 
skills or function, earlier marital breakdown, inadequate social networks, 
loneliness and isolation due to bereavement or retirement may affect 
use. There are indications that social factors influence outcome in late-life 
drinkers. Schutte et al (2003) followed the progress of 447 older former 
problem drinkers over 10 years and compared them with a group of lifetime 
non-problem drinkers. They found that 1.6 times more former problem 
drinkers died over the 10-year period than non-problem drinkers. Although 
most of the former problem drinkers continued to drink alcohol, they did 
so at levels below those of the lifetime non-problem drinkers. Risk factors 
for relapse among the former problem drinkers were a less severe drinking 
history, heavier baseline alcohol consumption and lower baseline income. 
The authors noted that, despite improvements in functioning, the former 
problem drinkers continued to have greater financial, health-related and 
life-context deficits compared with the lifetime non-problem drinkers. They 
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concluded that drinking history is as valuable as current drinking behaviour 
when considering alcohol consumption by older people, and that the long-
term effects of problem drinking on finances, health and lifestyle persist, 
even when remission is maintained.
psychosocial risk facTors for alcohol misuse
Most alcohol misuse problems among older people are dealt with in primary 
care. Particular risk factors for alcohol misuse have been identified, including 
homelessness, bereavement, retirement and depression. In the UK, 40% 
of older homeless men are known to be heavy drinkers or to have alcohol-
related problems. The problems are most pronounced among men in 
their 50s. The majority of these men are White British or Irish, with only 
a small proportion from minority ethnic groups (Crane, 1998; Crane & 
Warnes, 2001). 
The relationship between bereavement and alcohol misuse is complex. 
In a cohort study of male community residents aged 65 years and over, 
recently widowed men were assessed at 6 weeks, 6 months and 13 months 
after bereavement and age matched with married men who were followed 
up at the same time intervals. Although similar proportions of older 
widowers and married men reported drinking alcohol, recently widowed 
older men reported significantly greater frequency and quantity of alcohol 
consumption than married men: 19% of widowers and 8% of married men 
reported drinking five or more standard drinks per drinking day (Byrne et al, 
1999). However, this finding is at odds with a study in Liverpool reporting 
no significant difference between the rates of regular drinking among 
married men and men who had been widowed 3 years earlier (Saunders 
et al, 1989). It is possible that the excess alcohol consumption of recently 
widowed older men diminishes after the first year following bereavement. 
Using a longitudinal approach, a study examining the impact of negative life 
events on alcohol consumption among 2040 men and women aged 65 and 
over found that, in men who were married at baseline, death of a spouse 
did not independently predict change in alcohol consumption. However, there 
was a significant interaction effect between death of a spouse and baseline 
alcohol consumption, with men who consumed greater amounts of alcohol 
at baseline being more likely to increase their alcohol consumption following 
bereavement (Glas et al, 1995). It would appear that conjugal bereavement 
in men increases the risk of alcohol misuse in established drinkers.
Retirement is an important landmark during a lifetime. In a long-
term follow-up of men who had successfully completed a behavioural 
treatment programme for alcohol problems when they were over 60 years 
of age, participants were contacted between 2 and 4 years after the end 
of treatment. It was found that 71% of those who had not yet retired 
when successfully treated for late-onset abuse began drinking heavily 
again when they did retire (Carstensen et al, 1985). This finding has been 
replicated elsewhere (La Greca et al, 1988). However, the effect of reverse 
causality on the relationship between alcohol misuse and retirement cannot 
be overlooked, with evidence that men showing existing problems with 
alcohol misuse are more likely to retire than men without such problems 
(Bacharach et al, 2004). An understanding of different trajectories among 
older substance misusers may help in directing treatment towards those 
affected more severely (Jacob et al, 2009).
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key messaGes
  Late-onset substance misuse has different aetiological and demographic associations, 
and probably a better prognosis, than early-onset misuse
  In older people, the relationship between cognitive function and substance (particularly 
alcohol) use is complex, as is that between functional mental health problems (e.g. 
anxiety and depression) and substance use. The direction of causality is often unclear
  Older men are at greater risk of developing alcohol and illicit substance use problems 
than older women. However, older women have a higher risk of developing problems 
related to the misuse of prescribed and over-the-counter medications
  Physical health problems and the long-term prescription of medication (especially 
hypnotics, anxiolytics and analgesics) are important factors in the development of 
substance misuse in older people
  Psychiatric comorbidities of substance misuse are common in older people (including 
intoxication and delirium, withdrawal syndromes, anxiety, depression and cognitive 
changes/dementia)
  Among older people, psychosocial factors (including bereavement, retirement, 
boredom, loneliness, homelessness and depression) are all associated with higher 
rates of alcohol use
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Effects and complications 
A detailed review of the physical and psychiatric complications of substance 
misuse by older people is beyond the scope of this report. A comprehensive 
account of such complications can be found elsewhere (e.g. Crome & Day, 
2002; Crome & Bloor, 2005b).
physical complications 
The most common problems related to substance misuse by older people 
are the cardiovascular and respiratory problems associated with smoking 
and alcohol, both exacerbated by lack of exercise. The biggest problem by 
far is alcohol misuse, as older drug users also move from illicit drugs to 
use of alcohol or of both substances. Since about 50% of intravenous drug 
users have hepatitis C, liver disease advances rapidly. There is a high level 
of lung disease, particularly chronic obstructive pulmonary disease (COPD) 
secondary to long-term smoking of tobacco, crack cocaine and heroin. There 
is early morbidity with co-infection of hepatitis B and C. 
Older people are particularly at risk from the harmful effects of 
substances because of polypharmacy (Crome, 2005) and altered metabolism 
(Dunne & Schipperheijn, 1989). As people age, there is a fall in the ratio 
of body water to fat, decreased hepatic blood flow and inefficiency of liver 
enzymes. The responsiveness of the brain alters, so that alcohol produces 
a more rapid depressant effect, resulting in, for example, impaired 
coordination and memory. 
Apart from the direct effects of drugs on general health, there are 
indirect effects such as dietary neglect due to impoverishment, depression 
and isolation. Malnutrition, for instance, may result from drug-induced 
anorexia, malabsorption and/or economic deprivation. Liver dysfunction 
associated with, for example, HIV, hepatitis B and C, produces psychological 
as well as physical problems.
The presentation of such problems can be subtle or non-specific and 
underdiagnosis and/or underreporting may therefore have contributed to 
unreliable estimates of the level of problems associated with substance 
misuse (O’Connell et al, 2003). One Australian study found low levels of 
detection and appropriate onward referral to specialist services of older 
substance misusers by medical staff, some of whom believed that ‘to give up 
established habits is inappropriate’ (McInnes & Powell, 1994). 
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psychiatric complications 
The co-occurrence of psychiatric disorder and substance misuse (dual 
diagnosis) can have a range of differing psychological effects, including 
those caused by intoxication and withdrawal (Banerjee et al, 2001; Crome 
& Day, 2002; Day & Crome, 2002; Waller & Rumball, 2004). Chronic use, 
intoxication with depressant drugs and withdrawal from stimulants produce 
symptoms similar to those of depressant drugs, including suicidal intent. 
Acute intoxication with stimulants or cannabis may mimic a schizophrenic 
illness. Withdrawal from depressant drugs may result in symptoms of 
anxiety, panic and even confusional states. These complex interactions have 
implications: not only does drug use interfere with emotional, cognitive and 
social behaviour, but the combination of disorders results in poorer treatment 
adherence and poorer short- and longer-term outcome.
The interrelationships between physical health, mental health and 
drug misuse are well documented. Psychiatric conditions such as anxiety, 
depression, post-traumatic stress disorder, drug-induced psychosis, 
schizophrenia, delirium and dementia may lead to, be a consequence of, 
or coincide with drug misuse. Delirium is associated with withdrawal from 
barbiturates and benzodiazepines, but delirium and dementia are also 
associated with factors such as head injury and serious infection. The 
differing mechanisms and types of relationship demand careful history-taking 
and judicious interpretation. Among older people, depression, dementia, 
delirium and a heightened risk of suicide are probably the problems most 
commonly faced by clinicians. Of course, some of these conditions are 
associated with chronic pain and sleep disorders, which may make patients 
vulnerable and cause them to seek relief in inappropriate use of prescription 
and non-prescription medications. 
key messaGes
  Because of physiological changes associated with ageing, older people are at increased 
risk of adverse physical effects of substance misuse, even at relatively modest levels 
of intake
  Alcohol and tobacco use have the greatest impact in population terms on physical 
health, affecting many systems (including the cardiovascular, gastrointestinal, 
neurological and respiratory systems)
  Presentation can be subtle or non-specific and the aetiological role of substance use in 
physical conditions is frequently overlooked
  Psychiatric comorbidities of substance misuse are common in older people (including 
intoxication and delirium, withdrawal syndromes, anxiety, depression and cognitive 
changes/dementia)
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Assessment of substance misuse  
in older people
case viGnette key points
This case illustrates several points regarding the assessment and management of alcohol 
problems in people with cognitive impairment:
  the value of taking a history from an informant
case viGnette 3
Mr D, a 72-year-old retired teacher, had been living alone in his own house since 
the death of his wife 3 years ago. He was referred to old age psychiatry services 
because of progressive memory changes over approximately 2 years. Other 
concerns included deteriorating self-care, poor appetite, weight loss and several 
falls. His daughter commented that he had episodes when he appeared much 
more muddled and that he was still driving, which caused her great concern.
Mr D was assessed at home with his daughter present, and was found to have a 
mild to moderate degree of cognitive impairment (Mini-Mental State Examination 
(MMSE) score of 20 out of 30) and the clinical picture was felt to be consistent 
with a diagnosis of Alzheimer’s disease. Mr D was unwilling, or unable, to give a 
clear account of his current level of alcohol intake. His daughter said that Mr D’s 
drinking had gradually increased since the death of his wife and she thought that 
he was probably consuming at least one bottle of wine a day. She had repeatedly 
asked her father to cut down his drinking, but to no effect (he was still buying his 
own alcohol from the local supermarket). The kitchen contained several empty 
wine bottles, as did the dustbin. There was no evidence of physical dependence, 
but his psychiatrist felt that his drinking was undoubtedly contributing to his 
episodes of more marked impairment and falls.
Mr D surrendered his driving licence and his daughter began to do the shopping 
and refused to buy alcohol for him. Initially, his cognitive state improved slightly 
and he put on some weight. After a few months, he deteriorated and started 
falling again; it was noted that significant amounts of money were missing from 
his bank account, as a neighbour had started buying alcohol for Mr D and had 
been taking financial advantage of him. Vulnerable-adult protection procedures 
were instigated and the police became involved. As Mr D now lacked the capacity 
to manage his affairs, and had not previously made a lasting power of attorney, 
an application to appoint a receiver was made to the Court of Protection. 
Unfortunately, Mr D continued gradually to deteriorate and was eventually placed 
in residential care.
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  the value of home assessment (allows inspection of the environment for evidence of 
alcohol use)
  the enhanced effects of alcohol in people with underlying cognitive impairment 
(including worsening cognitive function and falls)
  significant improvement can occur if people stop drinking
  a particular vulnerability to exploitation
  if patients are found to lack capacity in particular areas (e.g. management of finances) 
then one should follow the principles of the Mental Capacity Act 2007 and take 
decisions that are in their best interests
case viGnette key points
  Substance misuse can occur at unexpected stages in older users, even in in-patient 
care
  Families can be complicit in substance misuse
  Individuals can hide and deny illicit drug use when least expected
barriers anD obstacles – ‘if you Don’t think about it, 
then you Won’t see it’
Full assessment of a patient entering a substance misuse unit is often 
carried out over a number of interviews and examinations and may amount 
to several hours. Engagement of older patients often requires a degree of 
common sense and change in policy. For moderate- to long-term retention 
in treatment, making the patient welcome, listening and being empathetic 
may be more important than simply gleaning information.
The lack of awareness and knowledge regarding alcohol and substance 
use disorders in older people is a major barrier to detection and diagnosis 
(Table 2). The traditional view that alcohol misuse is uncommon in older 
people and that the misuse of other substances is very rare means that 
clinicians fail to ask about misuse and also leads them to overlook or 
discount evidence of such problems. Stereotyped views regarding ‘typical’ 
case viGnette 4
Mr C was admitted to a care home and was on a low dose of methadone. He 
accepted the decision to withdraw his methadone over the course of a few weeks. 
Before closing the case, the care coordinator was asked to visit Mr C at the nursing 
home and, if possible, obtain a urine test. On visiting, the patient was assertive that 
he did not need any further visits or follow-up as he was now doing well. This was 
confirmed by a urine test that was negative for all substances – apart from cocaine!
27Royal College of Psychiatrists
Assessment of substance misuse in older people 
profiles of alcohol and substance misusers hinder accurate identification. 
For example, binge drinking, rather than chronic heavy drinking, occurs in 
14% of men and 3% of women aged over 65 (Blazer & Wu, 2009). 
Signs and symptoms of substance misuse may be mistakenly attrib-
uted to other physical or mental health conditions, or may be masked by the 
presence of other illnesses. Thus, an underlying substance use disorder may 
be missed unless a high degree of clinical suspicion is maintained. 
Physical symptoms that should trigger screening include the following 
(Blow et al, 1998):
  sleep complaints
  cognitive impairment, memory or concentration disturbance
  seizures, malnutrition, muscle wasting
  liver-function abnormalities
  persistent irritability without obvious cause
  unexplained chronic pain or other somatic symptoms
  incontinence, urinary retention
  poor hygiene and self-neglect
  unusual restlessness and agitation
  complaints of blurred vision or dry mouth
  unexplained nausea and vomiting
  changes in eating habits
  slurred speech
  tremor, poor motor coordination, shuffling gait
  frequent falls and unexplained bruising.
Clinicians may be embarrassed to ask about substance use, and 
patients, relatives and carers may be reluctant to reveal information for a 
variety of reasons, including shame, denial or a desire to continue using the 
Table 2 Barriers to identification of substance misuse in older people
Practitioner barriers Individual barriers
Ageist assumptions
Failure to recognise symptoms
Lack of knowledge about screening
Discomfort with topic
Lack of awareness of substance misuse in older 
people (‘If you don’t think about it, you won’t 
see it’)
Misuse traditionally considered to be rare in old 
age
Symptoms may mimic or be hidden by 
symptoms of physical illness
Unwillingness to ask
Absence of informants
Attempts at self-diagnosis
Symptoms attributed to ageing process or other 
illness
Many do not self-refer or seek treatment
Perceived stigma of the word ‘addiction’
Reluctance of patients to report – shame, 
denial, desire to continue using, pessimism 
about recovery
Cognitive problems – substance-induced 
amnesia, underlying dementia
Unwillingness to disclose
Collusion of informant(s)
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substance in question (Table 2). Assessing levels of consumption in patients 
with cognitive impairment, especially in the absence of a reliable informant, 
is particularly problematic. Screening instruments may not be appropriate 
for an older population, and criteria such as ‘safe limits’ (see pp. 35–36)
for alcohol consumption may be set too high to be of valid use with elderly 
people. The belief that ‘nothing can be done’ because of the person’s age, 
or that it would be ‘cruel’ to take away an activity that appears to provide 
some degree of comfort, may be other factors that result in the under-
diagnosis and under-treatment of such problems in older people. Even when 
misuse is detected and diagnosed, elderly people are less likely to be given 
adequate treatment or to be referred to specialist services (O’Connell et al, 
2003). Possible explanations for this are that, in some localities, they are 
excluded from specialist treatment on the basis of age or that facilities are 
not available in their area.
screeninG tools 
Screening should never be considered as a substitute for a thorough 
clinical assessment. However, appropriate screening tools can be useful 
in identifying patients at high risk, who should then be comprehensively 
assessed (Table 3). To the best of our knowledge, all of the literature 
regarding screening for substance use disorders in older people relates 
to alcohol, mainly using self-report instruments developed for use in 
younger populations (although some have been adapted for older people). 
It is important that screening for substance misuse in older patients is 
undertaken using age-appropriate instruments, if available, or that if the 
instruments standardised on working-age adults are used then this is taken 
into account (Beresford, 2000). 
The utility of alcohol screening tests with older people has been 
systematically reviewed, both for in-patient populations (O’Connell et 
al, 2004) and in primary care (Berks & McCormick, 2008). The general 
conclusions of these reviews are that, although the CAGE questionnaire 
(Ewing, 1984) is well-known and quick to perform, its primary purpose is 
in detecting alcohol dependence and it is relatively insensitive to harmful/
hazardous drinking. The CAGE has been validated in samples of older people, 
but in one study up to 60% of older people at risk of alcohol dependence in 
a community sample were CAGE-negative (Adams et al, 1996). Therefore, if 
the CAGE is used, it should be combined with careful assessment of current 
consumption. 
Table 3 Goals and rationale for screening older people for alcohol problems
Identification goals Rationale
Low-risk drinking (less than 21 units per week 
for men and less than 14 units per week for 
women)
Incidence is high enough to justify routine 
screening
Hazardous drinking (22–50 units per week for 
men, 15–35 units per week for women)
Adverse effects on health and quality of life may 
be significant
Dependent drinkers (more than 50 units per 
week for men, more than 35 units per week for 
women) 
Effective treatments exist
Need for further assessment and treatment Available treatments are cost-effective
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The Short Michigan Alcoholism Screening Test – Geriatric version 
(SMAST-G; Blow et al, 1998) has been validated for use in older hospital 
in-patients (Joseph et al, 1995). It is longer than the CAGE and not as well-
known but it may be useful in specialist settings.
The Alcohol Use Disorders Identification Test (AUDIT) is a 10-item 
self-report questionnaire developed to identify both alcohol dependence and 
hazardous use in adults (Saunders et al, 1993). Various adaptations have 
been made and tested in older populations. These include the AUDIT-5, a 
five-item version of the full AUDIT (Piccinelli et al, 1997) and the AUDIT-C, 
which asks only the three alcohol consumption questions of the full AUDIT 
(Bush et al, 1998). 
A study comparing the MAST-G and AUDIT with the Alcohol-Related 
Problems Survey (ARPS) and the Short Alcohol-Related Problems Survey 
(shARPS) reported that the ARPS has some advantages over the MAST-G in 
older patients in a primary care setting (Moore et al, 2002). 
Given the paucity of specific instruments for screening for alcohol 
problems in older people, the use of a combination of methods is advised 
(Reid et al, 2003). Existing screening tools can increase the detection of 
alcohol problems in this population, but a more comprehensive framework 
for assessing and managing alcohol- and drug-related problems is 
recommended and is a useful way of formulating the assessment process, 
as it translates into specific management plans (Raw et al, 1998). 
assessment
The key to appropriate management is the taking of a thorough history 
(Crome & Bloor, 2005a,b, 2006; Crome & Ghodse, 2007), although clinicians 
may be reluctant to observe this degree of rigour in assessing older people. 
They may lack confidence in what to ask and experience or support in what 
to do; they may rationalise older people’s substance use (e.g. ‘Drinking is all 
they’ve got’) or deny that the problem exists in this age group. Of course, 
older people and their relatives may be reluctant to disclose and/or may not 
realise the extent of the problem.
Assessment should include a full history (including a collateral history 
from a suitable informant), mental state examination, physical examination 
and further appropriate investigations. The assessment will need to cover 
current and past levels of substance use, frequency of use and quantity of 
substances taken, route of ingestion, evidence of withdrawal symptoms and 
other features of physical and psychological dependence, context of use, 
and the physical, psychological and social consequences of prolonged use. 
Questions will need to be phrased in a sensitive, non-judgemental fashion. 
It is often helpful to ask questions that address the presence or absence 
of ICD-10 or DSM-IV diagnostic criteria for harmful use, dependence and 
withdrawal (O’Connell & Lawlor, 2008). 
It is particularly important to consider alcohol and other substance 
misuse in patients who repeatedly present with unexplained falls and 
fluctuations in their physical or psychological state, or in patients who do well 
in hospital only to relapse again on their return home. 
A simple model, which has a similar approach to that of the five-phase 
framework (Ask, Assess, Advise, Assist, Arrange: see Appendix 1), has been 
used with older patients with substance use problems (Kaempf et al, 1999). 
During all phases, close attention should be paid to the appropriateness of 
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key messaGes
Screening
  Screening should be user-friendly and take account of sensory, cognitive, 
environmental and other specific needs (e.g. cultural background and ethnicity)
  General practitioners should screen every person over 65 years of age for substance 
misuse as part of a routine health check, using specific tools such as the SMAST-G; 
screening should also incorporate cognitive testing using tools such as the MMSE
  Re-screening should be carried out if certain physical and/or psychological symptoms 
are present or if the person is experiencing major life events
  Questions should be linked to medical conditions or health concerns 
Assessment leading to a diagnosis of dependence
  Although applying the standard diagnostic criteria for substance use disorders is useful, 
it should be noted that sometimes they may not be appropriate for older people
  Patients who repeatedly do well in hospital and badly at home, those with unexplained 
‘ups & downs’ in health presentation, those with inconsistencies and contradictions in 
the history and presentation are of particular concern
Physical assessment
  Association of substance misuse (particularly alcohol) and conditions such as liver dis-
ease, hypertension, diabetes, falls, cognitive problems, depression, self-harm, inconti-
nence (often not a readily apparent association) indicates specific physical investigations
  Useful standard investigations: FBC, MCV, B12 and folate, LFTs, urine/blood/breath 
alcohol levels and/or drug screens
  Special investigations: neuroimaging, blood-borne virus screening if indicated
various options for the particular individual, i.e. they should be ‘tailor-made’ 
where possible (U.S. Department of Health and Human Services, 2005). 
There are clear associations between substance misuse (particularly 
alcohol) and a variety of physical conditions, including: liver disease, 
hypertension, diabetes, falls, cognitive changes, depression, self-harm 
and incontinence. However, these associations can be very non-specific 
and difficult to pick up. Alcohol (or other substance) misuse should always 
be considered as a possibility in patients presenting with these problems. 
Conversely, a full physical and mental state assessment focusing on these 
areas should be performed in any patient suspected of misusing alcohol or 
other drugs. Often, further investigations (such as urine or breath tests, 
blood alcohol levels, full blood count (FBC), mean corpuscular volume 
(MCV), urea and electrolytes (U&Es), liver function tests (LFTs), vitamin B12 
and folate levels) will be required. If clinically indicated, more specialised 
investigations such as neuroimaging studies or screening for blood-borne 
viruses may have to be considered (O’Connell & Lawlor, 2008). 
In the case of illicit drug use, urine testing is a useful objective 
measure, although the window for detection in the urine is often brief. 
The use of a breath alcohol meter in the clinical setting provides valuable 
evidence of inappropriate alcohol levels and can aid diagnosis of a 
dependence syndrome (Han et al, 2009). 
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Treatment of addiction
It is important to note that many of the drugs used in the treatment of 
addiction are not used in everyday clinical practice by either old age or 
addiction psychiatrists for patients over the age of 60. However, it is vital to 
point out that older people can and do benefit from treatment. 
The Mesa Grande project from the USA (Miller & Wilbourne, 2002) 
is the largest systematic review of controlled trials comparing treatment 
for alcohol use disorders, but it does not provide evidence for treatment 
outcomes specifically for the over-65s. Similarly, other UK-based 
observational and analytical studies of drug and alcohol treatment outcomes 
have not included older adults. 
There is a vast literature on pharmacological and psychological 
treatments for adult substance misusers, from which evidence-based 
guidance and numerous consensus statements have resulted (Lingford-
Hughes et al, 2004; National Collaborating Centre for Mental Health, 
2007a,b; National Institute for Health and Clinical Excellence, 2007a,b). A 
detailed discussion of these is beyond the scope of this report, but the list of 
online resources in Appendix 4 and the reference list should direct readers 
to related documents and organisations. Appendix 2 offers a summary of the 
guidance from some of these sources.
The National Institute for Health and Clinical Excellence (NICE) has 
issued no guidance on the treatment of substance misuse in general or 
opiate dependence in particular in older people (National Collaborating 
Centre for Mental Health, 2007a,b; National Institute for Health and Clinical 
Excellence, 2007a,b). The studies on which its recommendations are based 
usually exclude those over 65 (sometimes even those over 50), as well as 
those with physical and psychiatric comorbidity. The Department of Health’s 
guidelines on drug misuse and dependence include a brief section on older 
addicts (where the older patient is defined as 40+ years), but little specific 
detailed information on management is provided (Department of Health, 
2007). The National Service Framework for the care of older people does 
not discuss addictions and substance misuse (Department of Health, 2001).
In a literature review carried out to determine whether there is 
evidence to support the treatment of substance misuse in older people 
and to identify which treatments, if any, are appropriate for this population 
(Moy et al, 2011), older people were defined as those aged 50 and above. 
Sixteen studies were found to fit the inclusion criteria and were categorised 
according to the British Association for Psychopharmacology consensus 
statement (Lingford-Hughes et al, 2004). Eleven studies related to alcohol 
misuse (Dupree et al, 1984; Fleming et al, 1999; Blow et al, 2000; Gordon 
et al, 2003; Lemke & Moos, 2003a,b; Oslin et al, 2002, 2005; Satre et al, 
2003, 2004a,b), three to nicotine dependence (Vetter & Ford, 1990; Morgan 
et al, 1996; Schroeder et al, 2006), one to opiate dependence (Firoz & 
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Carlson, 2004) and one to dependence on prescription medications (Brymer 
& Rusnell, 2000).
Moy et al (2011) report that, despite the current and potential future 
impact of substance misuse on an ageing population, little research is being 
conducted into the treatment of substance misuse in older patients. They 
conclude that the evidence to date indicates that, if treated, older people 
do not have worse outcomes than their younger counterparts and in some 
cases even do slightly better. It does appear that older people can respond 
to treatments that have been developed and tested in younger populations. 
Standardisation of age range, diagnostic tools and assessment instruments, 
treatment options and style of delivery would enhance comparability. 
A study by Brennan et al (2003) indicated that access of older 
substance misusers to specialised out-patient mental health services was 
similar to that of younger patients and that they showed better outcomes. 
Older patients were less likely to be experiencing drug problems and 
psychiatric problems, but were more likely to report alcohol and medical 
problems. This equality of access was despite the fact that older people 
perceived the relative importance of treatment for psychological problems to 
be less than did younger people. The authors raise the interesting question 
of whether older people are more robust than younger people or whether 
there is a cohort effect in accepting that psychological factors play a role in 
both aetiology and recovery. 
In this context, a meta-analysis of brief interventions for problem 
drinking (Cuijpers et al, 2004) demonstrated that they appear to reduce 
mortality. This has far-reaching implications for public health measures and 
the role of primary care and, potentially, has application to the drug-misusing 
population. It should be noted that key components of brief interventions 
include therapist characteristics (e.g. development of a therapeutic alliance, 
competence, adherence to treatment plan); user characteristics (e.g. culture, 
ethnicity and gender); and setting (e.g. whether conditions are optimal for 
the purpose) (National Treatment Agency for Substance Misuse, 2006).
Satre et al (2004a) conducted a comparative study of the 5-year 
outcomes of a group of older adults (aged 55–77) v. younger and middle-
aged people after alcohol and drug treatment. They found that the older 
adults were less likely to be drug dependent at baseline than younger (aged 
18–39) and middle-aged (aged 40–54) adults, and had longer retention 
in treatment than younger adults. At 5 years, older adults were less likely 
than younger adults to have close family or friends who encouraged alcohol 
or drug use. Fifty-two per cent of older adults had been totally abstinent 
from alcohol and drugs in the past 30 days v. 40% of younger adults. Older 
women had higher 30-day abstinence rates than older men or younger 
women. Thus, although older adults had a favourable long-term outcome, 
these differences may be accounted for by variables associated with age, 
such as type of substance, retention in treatment, social network or gender. 
These results provide valuable information on which to base service provision 
for older people: for example, persistence in treatment has long-lasting 
benefits, adequate social support is important, and family and friends are 
less likely to encourage substance use.
The treatment of substance misuse in older people also needs to take 
account of comorbid physical problems such as neuropsychiatric disorders 
and hepatic complications (e.g. alcoholic liver disease and hepatitis C), as 
well as respiratory complications such as chronic obstructive pulmonary 
disease (COPD). Clinicians should discuss with patients options and plans for 
terminal and palliative care and end-of-life treatment.
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Most pharmacological agents should be used with caution, as 
pharmacokinetic and pharmacodynamic considerations mean an inevitable 
dosage reduction and careful monitoring in older people. 
We are unaware of any specific guidance on the use of acamprosate, 
naltrexone, disulfiram, methadone or buprenorphine with older people. 
Addiction psychiatrists initiating treatment in older people should therefore 
work jointly with old age psychiatrists and/or geriatricians and frequently 
monitor treatment. 
cost-effectiveness
Treating people with alcohol use disorders is cost-effective. For every £1 
spent on treatment, the public sector saves £5. Providing alcohol treatment 
to the 10% of the population with dependent drinking in the UK could reduce 
costs by between £109 million and £156 million each year (South West Public 
Health Observatory, 2008). There are no comparable data confined to older 
people so the cost-effectiveness of treatment for substance misuse in this 
population remains to be evaluated.
family anD carers
There is little literature concerning carers of older people with substance 
misuse. However, there are two relevant points to highlight. First, carers 
are central to the detection of alcohol misuse and the majority are aware 
of referral pathways (Wesson, 1992). However, their apparent lack of 
awareness of alcohol as a causative or contributing factor may result from 
their reluctance to judge the role of alcohol in the life of the person for 
whom they care. Second, the risk to older people from other older and 
younger people with alcohol misuse has potentially serious consequences for 
safeguarding older drinkers, who are already vulnerable to abuse (Homer & 
Gilleard, 1990; Reay & Browne, 2001).
key messaGes
  There is a paucity of UK-based research and evidence for treatment interventions and 
services relating to the management of substance use disorders in older people
  Older people can and do benefit from treatment and in some cases have better 
outcomes than younger people
  Treatment of alcohol misuse in older people appears to reduce mortality
  Treatment of coexisting physical conditions (including chronic conditions such as 
hepatitis C and chronic obstructive pulmonary disease) and psychological conditions is 
a very important part of management
  Close liaison between all professionals, disciplines and agencies involved in the care of 
the patient is very important
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case viGnette key points
  Changes in social circumstances such as bereavement may be powerful precipitants 
of alcohol misuse 
  There may be problems in joint working between specialist teams, particularly where 
patients ‘fall through’ gaps in service provision
  The inclusion of social (including family) support in the treatment package is an 
essential factor in reducing harm and improving health and social function
case viGnette 5
Mrs E is an 81-year-old widow living in sheltered accommodation. She was referred 
to the specialist community alcohol team by the older adults team, to whom she 
had originally been referred by her GP. She suffered from recurrent depressive dis-
order and her GP had prescribed an anti depressant as well as sedatives. Mrs E’s 
relationship with her daughter was strained and there were concerns about her 
safety after she was found walking the streets in her nightdress in the early hours 
of the morning. She had previously sustained injuries following falls and, 6 years 
earlier, had consulted a neurologist for ‘resting tremor and cogwheel rigidity’. 
Mrs E reported a 5-year history of alcohol dependence following her husband’s 
death. After admission for in-patient alcohol detoxification, she was referred to the 
older adults psychiatric team, but the referral was not accepted. She was therefore 
supported in the community by the community alcohol team before discharge to her 
GP. The GP re-referred Mrs E after a matter of weeks, following concerns regarding 
her safety secondary to falls and cognitive impairment. There was deterioration in 
the relationship with her daughter, who had distanced herself from her mother’s 
care. A re-referral to the older adults team was declined. Social Services input was 
sought and put in place. This included attendance at a day centre and input from a 
home care service, following which Mrs E was again discharged to her GP.
case viGnette 6
Mrs F is a 66-year-old living with her partner (aged 52). Both have been on stable 
methadone maintenance for over 10 years (Mrs F was prescribed a daily dose of 
80 mg) and were being managed through a shared-care arrangement between their 
GP and the local drug and alcohol service. Mrs F was referred to old age psychiatry 
services because of concerns regarding her cognitive state. On assessment she was 
found to have significant impairment (MMSE score of 16 out of 30). Her partner 
indicated that he felt ‘unable’ to look after her any longer and said he intended 
to leave the relationship. She was admitted to a dementia assessment ward, 
where her 80 mg dose of methadone was continued, but she very rapidly became 
oversedated and the dose was reduced. It was suspected that her partner had 
either been using or selling part of her daily prescription. Following discussions 
with the local drug and alcohol service, the consultant old age psychiatrist decided 
that the methadone should gradually be withdrawn in order to assess its effect 
on Mrs F’s cognitive function. Following this withdrawal, she showed a marked 
improvement in cognition and self-care (MMSE increased to 24 out of 30). She 
underwent full investigations (including for blood-borne virus infections) and was 
diagnosed as having a late-onset dementia secondary to Alzheimer’s disease. Her 
partner had ‘disappeared’ at this stage, and Mrs F was discharged into sheltered 
accommodation with Social Services support. 
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case viGnette key points
This case illustrates several points regarding the assessment and management of opiate 
use in people with cognitive impairment:
  such patients are very vulnerable and readily exploited
  opiates at high doses can have a significant deleterious effect on cognitive function, 
particularly in patients with underlying cognitive impairment
  close, joint working between the different teams involved in the care of these patients 
is essential
alcohol misuse anD olDer people: shoulD GuiDelines 
for ‘sensible limits’ be moDifieD?
Sensible limits for alcohol consumption by older people need to be re-
examined. Effects of the ageing process and metabolic changes probably 
mean that they are lower than the limits recommended by the World Health 
Organization for men and women of working age.
The concept of ‘sensible limits’ in assessing harm from alcohol is 
now more than 15 years old. Over the past 5 years, new evidence has 
emerged that suggests that guidelines for people aged 65 and over should 
be changed. The original concept of drinking over ‘sensible limits’ arose 
from a consensus statement from a working group of the Royal Colleges 
of Physicians, Psychiatrists and General Practitioners in 1995, defining 
recommended weekly limits of 21 units of alcohol for men and 14 units 
for women (Royal College of Physicians, 1995). To improve the accuracy 
of these recommendations in relation to drinkers who concentrate their 
alcohol consumption over a shorter time and remain under the threshold for 
recommended weekly limits, the Department of Health (1995) defined these 
limits in terms of units of alcohol per day: a maximum of 4 units per day for 
men and 3 units for women.
Older people tend to show higher blood alcohol levels than younger 
people on drinking the same amount of alcohol. This difference is attributable 
to a lower body mass : water ratio and less efficient alcohol metabolism in 
older people. In older drinkers, there is also ample evidence for alcohol-
related harm at lower levels of alcohol intake compared with younger 
people. For example, increased body sway in older people is associated with 
normal blood alcohol levels (Beresford & Lucey, 1995). Drinking more than 
13 units of alcohol per week for either men or women over 65 is associated 
with impairment in activities of daily living (Moore et al, 2003). More recent 
evidence from the USA, based on alcohol-related harm/alcohol misuse, has 
defined ‘at-risk’ drinking in older people as being more than 1.5 units of 
alcohol on any one day or more than 11 units per week for both men and 
women (National Institutes of Health, 2005). The most recent evidence 
suggests that more than 3 units per day and 11 units per week for older 
men and women are associated with alcohol-related problems. Whereas 
in younger people, acute heavy (‘binge’) drinking is defined as 8 or more 
units in a single session for men and 6 units for women, the corresponding 
limits for older men and women are 4.5 and 3 units respectively (Moos 
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et al, 2009). Recommended limits for safe drinking by older people in the 
UK require further consideration to address the problem of a growing older 
population, in whom the cohort effects of changing drinking habits are likely 
to be associated with an increasing public health burden from alcohol-related 
morbidity and mortality.
key messaGes
  Current recommended ‘safe limits’ for alcohol consumption are based on work in 
younger adults. Because of physiological and metabolic changes associated with 
ageing, these ‘safe limits’ are too high for older people
  Recent evidence suggests that the upper ‘safe limit’ for older people is 1.5 units per 
day or 11 units per week
  In older people, binge drinking should be defined as >4.5 units in a single session for 
men and >3 units for women
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policy anD pracTice – where are we now? 
Few models have been developed to address the needs of older people with 
substance misuse within the UK’s National Health Service (two of these are 
outlined in Appendix 3). However, there has been considerable development 
in the voluntary sector, with alcohol and drug treatment charities such as 
Foundation 66 promoting the case for better recognition and treatment of 
substance misuse – particularly alcohol misuse – in older people.
The current situation in terms of a policy framework for the prevention 
of substance misuse by older people and the planning and provision of 
services for its treatment is generally characterised by a disturbing silence. 
The National Service Framework for Older People (Department of Health, 
2001) did not acknowledge that addiction, in its broadest or narrowest 
sense, is of relevance to planning service provision for older people. There 
is no specific mention of substance misuse in policy documents from elderly 
care medicine, other than that relating to delirium or falls (British Geriatrics 
Society, 2006, 2007). 
Similar public health guidance, in Alcohol Use Disorders: Preventing 
the Development of Hazardous and Harmful Drinking (National Institute 
for Health and Clinical Excellence, 2010), makes even briefer reference to 
older people, highlighting that mortality in this group is influenced by alcohol 
pricing, suggesting the use of the AUDIT-5 as a suitable screening tool and 
emphasising the disparity between screening and brief intervention in older 
compared with younger people. 
The most significant advance in highlighting the need for assessment 
and treatment of alcohol misuse in older people has been the publication of 
the second report of the UK Inquiry into Mental Health and Well-being in Later 
Life (Age Concern, 2007). The report highlights several areas, notably:
  the high rates of alcohol-related deaths in the 55–74 age group
  the need to pay closer attention to ‘invisible’ groups such older people 
with alcohol and drug misuse problems
  epidemiology and psychosocial risk factors (including dual diagnosis, 
ethnicity and social isolation)
  physical and mental health consequences (such as falls and suicide)
  the detection, treatment and referral of older people with substance 
misuse, irrespective of age.
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As we were writing this report, the final draft NICE guideline Alcohol 
Use Disorders: Diagnosis, Assessment and Management of Harmful Drinking 
and Alcohol Dependence was published (National Collaborating Centre for 
Mental Health, 2011). Although it does not address alcohol misuse by older 
people in any great detail, it does highlight trends in a rising proportion of 
older men and women drinking above sensible limits (Department of Health, 
1995) over the past decade. The guideline also notes the rise in alcohol-
related mortality in older people, the need for lower doses of medication 
when managing alcohol withdrawal and need to redefine sensible limits for 
alcohol intake in this population. It emphasises that the threshold for alcohol 
misuse should be lowered when using screening instruments and assessing 
the severity of alcohol dependence, and highlights the need to consider in-
patient care more readily for detoxification. Furthermore, it draws attention 
to the fact that, although many drug treatments are not licensed for use in 
older people, there is no reason why they should not be considered clinically 
effective in this age group.
Our report demonstrates that it would be imprudent for policy makers 
not to take account of the multiple manifestations of substance use, misuse, 
harmful use and dependence as part of the phenomenon of polypharmacy 
and polysubstance misuse and dependence in older people, who often have 
multiple psychological, physical and social needs. Indeed, we would go so 
far as to say that it is an abuse of the trust older people still place in their 
physicians if any problem with which they present is not set in the framework 
and context of use of substances, be they prescribed, over the counter, licit 
or illicit, so that patients are offered optimal and quality treatments for these 
difficulties.
A very different picture has emerged in the USA, with a specific 
Treatment Improvement Protocol (TIP) guide for the implementation of 
substance misuse services for older people (U.S. Department of Health and 
Human Services, 1998) towards which we should aspire.
Substance misuse service provision for older people needs to tackle 
the deep-rooted age discrimination that has dominated mainstream addiction 
services in the UK. If needs are to be addressed, such discrimination is no 
longer appropriate or acceptable (Department of Health, 2009). Policies 
should be based on the agreement that patients should be able to access the 
most appropriate clinical service on the basis of need and that age must not 
be an exclusion criterion (Royal College of Psychiatrists, 2009). This principal, 
however, is likely to have an impact only if this subject is highlighted and 
given more than cursory mention in the policy documents that drive the 
prioritising and funding of healthcare problems. Even within professional 
bodies there has been no consensus on how to tackle this problem. 
However, the recent government initiative of positioning addictions as 
a public health priority and to create a new body, the Public Health Service, 
for this purpose (National Treatment Agency for Substance Misuse, 2010b) 
might provide an opportunity to advocate for this group and redress some 
of the problems highlighted.
Given that up to a third of older people with alcohol use problems 
develop them in later life (Council on Scientific Affairs, 1996), there are good 
reasons for targeting older people (in addition to the more usual focus on 
younger groups). Strategies could include: better education on the effects 
of alcohol and ‘safe’ limits for consumption for older people; restrictions on 
the advertising and pricing of alcohol; and increasing awareness regarding 
the potential problems of alcohol use in older people. Similarly, attempts 
39Royal College of Psychiatrists
Service models: implications for service development 
to reduce the misuse of prescribed and over-the-counter medications by 
increasing awareness and education of prescribers, dispensers and the 
general public, regular review of repeat prescriptions and possibly the use 
of ‘structured dispensing systems’ such as dosette boxes, blister packs and 
automated medication carousels may be effective in the primary prevention 
of medication misuse (O’Connell & Lawlor, 2008).
Focusing on groups of older people who are at particular risk of alcohol 
or substance misuse (e.g. those with a previous history or those experiencing 
stresses such as bereavement, retirement, social isolation, physical or mental 
health problems), perhaps administering screening instruments, could 
identify individuals at an early stage, preventing morbidity and mortality 
and reducing costs to the whole healthcare system. As this needs to be done 
mainly at a primary care level it would be a public health initiative.
The Department of Health and the Royal College of Psychiatrists 
consider that, owing to their skills and experience, consultant addiction 
psychiatrists have a unique contribution to make (Royal College of Physicians 
& Royal College of Psychiatrists, 2001; Royal College of Psychiatrists, 2005). 
Addiction psychiatrists are best placed to develop the knowledge, skills and 
attitudes required in the treatment of older people with substance misuse, 
as they will have had experience in dealing with the most complex cases and 
providing clinical leadership. Although a sizeable minority of their patients 
will need the help of a specialist addiction psychiatrist, clinicians who come 
into contact with older substance misusers in their everyday practice, be 
they working as old age psychiatrists, geriatricians, liaison psychiatrists, 
general practitioners or in forensic psychiatry, would benefit from the skills 
sharing that specialist addiction psychiatrists might offer. Older people 
with alcohol and substance use problems are likely to present to a wide 
variety of health services, including primary care, general hospitals (e.g. 
accident and emergency, medicine for the elderly, gastroenterology), old 
age psychiatry and specialist alcohol and drug services. The presentations 
are often non-specific and may mimic other disorders in presenting with 
physical illness, depression, anxiety, cognitive impairment, or delirium from 
alcohol withdrawal (Royal College of Psychiatrists, 2004). They also present 
to other agencies, such as Social Services and the police. In many cases, 
the underlying cause of the presentation (alcohol or substance misuse) may 
well be missed unless practitioners are aware of this possibility and maintain 
a high index of suspicion. 
The management of alcohol misuse in patients with cognitive impair-
ment or dementia often presents a significant clinical challenge. Usually these 
patients are felt to be unsuitable for specialist drug and alcohol services as 
they lack insight and motivation to accept help, and are unable to engage 
with or retain information from individual or group counselling. Care for this 
group is usually best provided by old age psychiatry services (with specialist 
input and advice from alcohol services and the general hospital where 
necessary). Management strategies will usually need to involve the patient’s 
family, Social Services and other formal and informal support networks. 
Often the problem has to be approached by environmental manipulation, 
for example working with the family to reduce the amount of alcohol they 
purchase or supply to the individual concerned. Sometimes the only way 
forward may be to ‘take control of the money supply’ (e.g. by activating a 
financial lasting power of attorney or referral to the Court of Protection), on 
the basis that this is in the older person’s best interests, or by moving the 
person into more supervised accommodation such as residential care.
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Within specialist services there is an obvious need for the development 
of clear local policies regarding older people with substance use problems. 
Policies should allow for easy transfer between services, joint working and 
should delineate clear arrangements for which service will take the lead 
where two (or more) are involved in the care of an individual patient. Policies 
should also cover arrangements for detoxification, including guidelines 
and administrative arrangements for organising in-patient detoxification 
on an elective and emergency basis, in a mental health unit or general 
hospital.
Training
In order to detect and manage alcohol and substance misuse in older 
people, appropriate training is required for all professional staff (including 
doctors, nurses, psychologists, allied health professionals and social workers) 
who encounter patients from this age group. Such education needs to 
begin at undergraduate level and progress through specialist training and 
continuing professional development (CPD). Addiction specialists and old age 
psychiatrists will have a particular role to play in providing such education, 
but a multidisciplinary approach will be necessary. Training programmes will 
need to increase levels of awareness and provide specific skills in screening, 
assessment, basic management and knowledge of referral pathways.
key messaGes
  Training about the impact of substance misuse on the older person is not an optional 
extra
  Training for all medical professionals should commence at under graduate level, through 
specialist postgraduate education and continue as part of continuing professional 
development (CPD)
  Old age psychiatrists, addiction specialists and psychiatrists, geriatricians, as well as 
nursing, psychology, social care and other allied professionals should be suitably trained
  It is essential that health professionals have adequate knowledge of substance use 
disorders in older people; this includes being aware of associations with mental 
disorders and physical health problems, as well as vigilance over interactions between 
substances and both prescribed and over-the-counter medications 
  Clinical skills in the areas of screening, assessing motivation to change substance using 
behaviours, as well as delivering brief interventions and social interventions to reduce 
relapse within a harm reduction model should be core competencies for health and 
allied health professionals
  Improved attitudes to older people with substance misuse in areas such as addressing 
stigma, therapeutic nihilism and social exclusion are required at individual, community 
and public health levels
  Local policies regarding older people with substance use problems should be developed: 
access on the basis of need, elimination of age barriers, easy transfer between 
services, joint working and decisions regarding who will be the lead service in these 
circumstances, as well as protocols regarding admission for detoxification
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research, evaluaTion anD auDiT
Research into substance misuse among older people in the UK has been 
highlighted as a significant gap (Crome, 1999, 2000). Most of the evidence 
showing the effectiveness of treating alcohol use disorders in older people 
originates in the USA. Much of this research is limited to White men in 
US veterans hospitals. Few empirical studies have compared treatment 
modalities and no studies have compared treatment with no treatment. 
Very few studies have looked at the safety and efficacy of pharmacotherapy 
to aid abstinence in this population (Dar, 2006). The positive results are 
preliminary, but they do provide an optimistic picture of the outcome for 
older substance misusers and form a basis for new research. Implementation 
should be cautious, but with a degree of confidence, so that patients are not 
denied effective treatments (Moy et al, 2011).
A comprehensive research programme is required which includes 
epidemiology, development of age-appropriate assessment instruments, 
evaluation of psychological and pharmacological treatments, longer-term 
outcomes, management within specific service models, and the roles of 
professionals and carers (Table 4). 
key messaGes
  Examination of trends in the extent, nature and predictors of substance use problems 
in older people is required
  Standardised age-appropriate assessment and outcome measures that encourage 
comparability should be developed
  Effective interventions for adults should be evaluated and innovative treatments for 
older people developed
  Service models with a particular focus on long-term outcome should be developed and 
evaluated
Table 4 Areas for future research 
Research area Focus Specific requirements
Epidemiology Regional, gender and diversity 
differences
Development of age-specific 
questionnaires to establish the scale of 
the problem in a variety of settings
Assessment Clinical needs of older adults Development of standardised age-
appropriate tools and protocols
Treatment Factors associated with treatment 
success and the safety of 
pharmacotherapy
Critical review and empirical 
implementation of treatment strategies 
used in adults
Specific efficacy and safety studies in 
older people
Optimum delivery of services to meet 
the special needs of older people 
Outcome Long-term outcomes of older adults 
with substance misuse
Development of appropriate 
methodologies with standardised 
outcome measures
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Fig. A1.1 A five-phase framework for assessing substance misuse in older patients (after Crome & Bloor 
2006).
Recent onset 
or early onset?
Abstinence 
or harm 
reduction?
Anxieties and 
concerns dealt 
with?
Set a quit 
date?
Is specialist 
input needed?
V?
Phase 2 - Assess
 Assess degree of dependence and educate patients about the effects of 
substances
 Assess the level of motivation or ‘stage of change’ at which the patient is 
and suggest staged goals, e.g. abstinence or harm reduction
 Discuss and negotiate treatment choices, e.g. pharmacological 
interventions, admission to specialist services
 Be aware that clinical manifestations of the condition and age-related 
effects such as neurocognitive dysfunction may impair history-taking
Phase 3 – Advise
 Use a brief 5–10 minute motivational interviewing framework
 Give the patient the opportunity to ventilate anxieties and concerns
 Offer feedback about clinical findings, including physical examination and 
biochemical and haematological tests
 Outline and discuss the benefits and risks of continued substance use; 
outline safe levels of drinking
 Provide self-help materials, e.g. manuals
Phase 4 – Assist
 Be supportive and encouraging, and instil positive expectations of success
 Acknowledge that previous failed attempts to cut down or give up may 
have engendered loss of confidence and self-esteem
 If the goal is abstinence, suggest that a quit date is set, so that the patient 
can plan accordingly (e.g. get rid of any alcohol in the house) and safely 
(e.g. is it safe abruptly to stop drinking?)
 Work through a range of alternative coping strategies, including the 
identification of cues that might help distract the patient
Phase 5 – Arrange
 Be prepared to refer or organise admission to a specialist or appropriate 
unit if the patient:
□ is in severe withdrawal, including delirium tremens
□ is experiencing unstable social circumstances
□ is likely to develop serious withdrawal symptoms owing to a severe 
dependence or previous severe withdrawal, including delirium tremens
□ is severely dependent
□ has a serious comorbid physical illness
□ has comorbid mental illness, including suicidal ideation
□ is using multiple substances
□ has a history of frequent relapse
Phase 1 – Ask
 Ask all patients about alcohol, drug, nicotine and other substance misuse, 
including prescribed and over-the-counter medications
 Differentiate between use, harmful use and dependence
 Consider using appropriate screening instruments
 Be aware of, and sensitive to, the ambivalence that patients may feel 
about their substance misuse
 Be non-judgemental and non-confrontational
V?
V?
V?
V?
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Each substance should be 
discussed separately
 Alcohol
 Amphetamines
 Benzodiazepines
 Cannabis
 Cocaine
 Ecstasy
 γ-hydroxybutyrate (GBH)
 Heroin and other opiates
 Methadone
 Nicotine
Episodes of treatment for  
substance problems
Medical history
Family history
Psychiatric history
 Age at which substance first tried
 Age at onset of weekend, weekly and daily 
use
 Pattern of use during each day
 Route of use (if applicable), e.g. oral, 
smoking, snorting, intramuscular, intravenous
 Age at onset of specific withdrawal symptoms 
and features of dependence syndrome
 Current use over previous day, week, month 
and maximum use ever
 Current cost of use
 How is use being funded?
 Periods of abstinence
 Relapse triggers
 Preferred substance(s) and reasons
 Dates, service, practitioner details, 
treatment/interventions, success or 
otherwise, relapse triggers
 Episodes of acute or chronic illness: 
respiratory, infective, HIV, hepatitis, injury 
(including accidents), surgery
 Admission to hospital, dates, problems, 
treatment and outcome
 History of substance misuse and related 
problems
 History of psychiatric problems, e.g. suicide, 
self-harm, depression, anxiety, psychotic 
illness
 Assessment by general practitioner for 
‘minor’ complaints, e.g. anxiety, depression
 Treatment by general practitioner with any 
psychoactive drugs
 Referral to specialist psychiatric services: 
dates, diagnosis, treatment and outcome
 Mental Health Act assessments
 Is there any debt to finance substance 
problems?
 Biochemical, haematological, urinary, 
salivary, sweat, hair, alcohol levels
 Family, friends and colleagues
 Social Services
 Criminal justice agencies
 Health services 
 Voluntary agencies
V
V
V
V
V
Financial situation V
Investigations V
Collateral information V
X
X
X
X
X
X
X
Fig. A1.2 Suggested outline for schedule of issues to be covered in assessment (after Crome & Bloor, 
2006).
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The guidance that follows is drawn partly from the consensus statement 
produced by the British Association for Psychopharmacology (Lingford-
Hughes et al, 2004) and from NICE and Department of Health guidelines that 
reflect the most up-to-date evidence available (Department of Health, 2007; 
National Collaborating Centre for Mental Health, 2007a,b; National Institute 
for Health and Clinical Excellence, 2007a,b) (see also Crome & Bloor, 2006). 
Note that all of those documents focus on the younger adult population. It 
is beyond the scope of this report to provide a comprehensive account and 
readers should consult appropriate sources on substance use problems.
Pharmacological treatments are usually reserved for patients who 
have substance dependence, and they are available to treat withdrawal 
syndromes, to maintain abstinence, to prevent complications (including 
vitamin replacement). Pharmacological interventions are also used to treat 
psychological and physical disorders in substance misusers.
manaGement of alcohol WithDraWal anD Detoxification
Although the basic mechanisms of alcohol withdrawal are not age dependent, 
there is evidence that alcohol withdrawal may be more severe and more 
prolonged in older patients in general hospital settings, compared with a 
younger age group (Liskow et al, 1989; Brower et al, 1994). This finding was 
not replicated in a study of older patients admitted to a detoxification unit, 
but the presence of a comorbid physical illness was an exclusion criterion 
in the study (Wetterling et al, 2001). The effect of comorbid physical illness 
in modifying the course of alcohol withdrawal syndrome in older patients 
has been investigated in a study of 892 patients in Poland (Wojnar et al, 
2001). This demonstrated that age itself did not affect the severity of the 
syndrome, but associated physical illness and age-related infirmities were 
a significant modifying factor. Alcohol withdrawal can be a life-threatening 
condition and prompt medical intervention is essential if there are major 
signs of withdrawal syndrome. 
From the evidence, it is clear that older people respond to interventions 
with the same degree of success as younger patients, and a review of the 
treatment of alcohol problems in older patients emphasised the importance 
of providing adequate pharmacological and psychosocial interventions for 
this population (Whelan, 2003).
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benzoDiazepines
There is evidence that different benzodiazepines are equally efficacious 
in managing alcohol withdrawal and detoxification (Whelan, 2003). For 
uncomplicated withdrawal, 20 mg of chlordiazepoxide four times a day for 
7 days, supplemented by additional treatment for symptom suppression, is 
‘typical’ in a younger adult, although age, degree of severity of dependence, 
and the need for seizure prevention should be taken into account. There 
is some evidence that alcohol withdrawal in older patients may be more 
severe and prolonged in general hospitals, but this may not always be the 
case (Wetterling et al, 2001; Crome & Bloor, 2006). In older patients, a 
lower starting dose of chlordiazepoxide is advised, with an increase in dose 
if withdrawal symptoms are not controlled. This is a clinical judgement, 
and the dose should be sufficient to be effective, but should take account 
of the patient’s overall clinical condition. A longer-acting drug may prevent 
seizures and delirium, but could lead to accumulation. Each patient should be 
assessed, treated and monitored regularly. Other methods of administering 
benzodiazepines are by ‘front-loading’ (i.e. until light sedation is achieved, 
at which point no further medication is given) or when ‘symptom-triggered’ 
(as opposed to a fixed regime). All these regimes require skilled staff. 
Best practice guidance for the use of benzodiazepines in older 
patients indicates that shorter-acting preparations are preferable (National 
Collaborating Centre for Chronic Conditions, 2010). The evidence for the use 
of lorazepam in the treatment of alcohol withdrawal syndrome in older people 
was reviewed by Peppers (1996) and has been incorporated in Canadian 
(Seeking Solutions Project, 2004) and American Medical Association (Mayo-
Smith, 1997) guidelines. Similar guidance is offered by the Dutch College of 
General Practitioners in their guidelines for the management of delirium in 
older people (van der Weele et al, 2003). The usual lorazepam regime for a 
younger adult would be a slow tapering dose starting at 2 mg four times a 
day; as with all detoxification regimes it is safest to titrate the dose against 
symptoms, which results in better control and a lower total dose. In older 
patients, particularly those with severe liver disorder, the risk of accumulation 
is reduced with shorter-acting preparations such as oxazepam.
chlormeThiazole 
Chlormethiazole is not recommended for older patients because of its effect 
on respiration, cardiovascular complications and the unpredictability of the 
serum levels achieved (Broadhurst et al, 2003).
carbamazepine
Carbamazepine has not been evaluated in older populations and is therefore 
not recommended.
Thiamine anD wernicke’s encephalopaThy
Despite the commonness of vitamin deficiency in alcohol dependence, 
the quality of evidence for the prevention and treatment of Wernicke’s 
encephalopathy is weak. A Cochrane review of the evidence for the efficiency 
of thiamine (vitamin B1) in treating Wernicke’s encephalopathy concluded 
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that, although there is good empirical evidence to support current best 
practice guidelines, there is insufficient evidence from randomised controlled 
trials to guide the clinician on the correct dose, frequency of administration 
or duration of treatment (Day et al, 2004).
The use of oral thiamine is not recommended in the treatment of 
Wernicke’s encephalopathy, as the levels reached from oral administration 
are not sufficient to address the deficiency. All patients at risk of developing 
Wernicke’s encephalopathy, particularly those with poor diet or malnutrition 
(Sgouros et al, 2004), should be given 250 mg thiamine intramuscularly 
or intravenously once daily for 3–5 days. For suspected or actual 
Wernicke’s encephalopathy, the recommendation is a minimum of 500 mg 
intramuscularly or intravenously three times a day for at least 2 days for as 
long as there is some improvement, followed by 250 mg once daily for 3–5 
days, depending on the response. Thiamine for parenteral administration 
is also available in formulations combining vitamins B and C. One such 
formulation (now withdrawn in the UK) was associated with a very small risk 
of anaphylaxis, mostly on intravenous administration (Committee on Safety 
of Medicines, 1989). Consequently, intravenous administration should ideally 
be given in facilities where anaphylactic shock can be treated. If delivery in 
the community is necessary, procedures should be followed to ensure safe 
administration (Lingford-Hughes et al, 2004).
treatment of opiate misuse
There is considerable evidence for the use of methadone, buprenorphine 
and α2-agonists (clonidine and lofexidine) in the management of withdrawal 
states, but it has been obtained in populations of younger adults. The choice 
of medication will depend on such factors as preferred duration of treatment, 
adverse effects (brachycardia and hypotension due to α2-adrenergic 
agonists) and the severity of withdrawal symptoms. Obviously, the patient’s 
clinical condition, degree of dependence and preference, together with the 
practitioner’s experience, will determine which drug to use.
Similarly, there is an established evidence base for methadone 
maintenance treatment and, more recently, for buprenorphine. Once again, 
this relates to younger people. There is inadequate evidence for treatment 
with naltrexone and injectable opioids, and for using coercive methods.
special consiDerations
alcoholic DemenTia anD alcohol-relaTeD DemenTia
The role of alcohol as the primary aetiological factor (primary alcohol 
dementia) remains uncertain. It is more likely that alcohol is a contributory 
factor for dementia (alcohol-related dementia). This dementia differs from 
other dementias both clinically and in radiological findings. Criteria for the 
clinical diagnosis of probable alcohol-related dementia include a clinical 
diagnosis of dementia at least 60 days after the last exposure to alcohol. The 
disorder is supported by the presence of any of the following: alcohol-related 
end organ (including neurological) damage; improvement/stabilisation of 
cognitive impairment and/or reversal of radiological changes after at least 
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60 days of abstinence; and neuroimaging evidence of cerebellar atrophy. The 
presence of language impairment, focal neurological signs and neuroimaging 
evidence of infarction/haemorrhage cast doubt on the diagnosis (Oslin et al, 
1998).
hepaTiTis c anD chronic obsTrucTive pulmonary Disease
Hepatitis C in combination with alcohol misuse is becoming a disease 
predominantly associated with older people (Cainelli, 2008). A similar 
observation has been made for chronic obstructive pulmonary disease 
associated with smoking (Huisman et al, 2005). In this context, clinicians 
should discuss options, recommendations and plans for terminal and 
palliative care and end-of-life treatment with older people who have 
developed these comorbid illnesses.
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service provision for olDer people With Dual 
DiaGnosis in south lonDon anD mauDsley nhs 
founDation trust, lonDon
North Southwark Community Team for Older People is a multidisciplinary 
community mental health team responsible for the assessment and treatment 
of older people with mental disorders, covering a large inner-city area of 
south-east London. The catchment area of approximately 13 000 people 
aged 65 and over has a sizeable population with a history of heavy drinking. 
This is influenced by the large number of older men who were previously 
employed on the docks and in the construction industry, environments that 
were associated with a culture of heavy drinking. However, this drinking 
culture has also been incorporated into the lifestyle of a number of older 
women, irrespective of their previous occupation. The team comprises a 
consultant psychiatrist, specialty doctor, four community psychiatric nurses, 
two occupational therapists, a consultant clinical psychologist, an assistant 
clinical psychologist and a social worker. The North Southwark team is unique 
in offering a service based on the what the Department of Health now calls 
‘New Ways of Working’ (Care Services Improvement Partnership & National 
Institute for Mental Health in England, 2007), although the service was set 
up in 1981, long before the government initiative was launched. 
The service (called the ‘Guy’s model’) was the first open-access service 
in the UK for older people’s mental health, accepting referrals from any 
source (including self-referrals) and offering a system of multidisciplinary 
assessment and case management across the range of specialties. It remains 
one of the few services in the country that has doctors as care coordinators/
key workers, thereby allowing a ‘hands-on’ approach to care and an in-depth 
experience of day-to-day management problems. This has been particularly 
advantageous in the area of dual diagnosis involving alcohol misuse, where 
the consultant psychiatrist is care coordinator for older people with complex 
problems relating to alcohol misuse, sharing expertise and seeking help from 
other specialties when required. 
In response to the considerable number of referrals of older people with 
alcohol misuse who were unable to access standard NHS substance misuse 
services, the team’s consultant psychiatrist has acquired particular expertise 
in the area of alcohol misuse, thereby enabling knowledge and skills to be 
shared with the rest of the team. This has been helped by the creation of 
a specialised support service (Older Adults Support in Southwark, OASIS), 
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which is jointly funded by the government’s Supporting People programme 
and Southwark Social Services. 
The provision of a specific service within the North Southwark team 
to meet the needs of older people with mental health problems and alcohol 
misuse took 10 years to accomplish. The main obstacle was that it had to be 
delivered within existing resources. The first seeds of change were sown in 
1999, when it was noted that up to 1 in 5 referrals to the team each month 
involved alcohol misuse, but the way in which the existing substance misuse 
service was set up meant that it was not suitable for the team’s home-based 
model of care. Furthermore, it lacked the age-specific knowledge, skills and 
attitudes necessary for effective treatment of older people. By 2002, it was 
noted that up to 50% of psychiatric admissions of older people involved a 
dual diagnosis, with alcohol misuse being central to the clinical problems. 
In 2003, an audit of the team’s case-load revealed that only 5% 
of clients showed evidence of alcohol misuse, but all those who did were 
drinking at harmful levels. As a result, the consultant psychiatrist on the 
team embarked on an MSc in clinical and public health aspects of addictions, 
providing much needed expertise to managing older people with substance 
misuse. Five years on, following a series of awareness seminars to GPs in 
the catchment area and the introduction of OASIS in 2005, the team was 
finally able to manage dual diagnosis involving alcohol misuse in older people 
more effectively, cutting down the percentage of mental health admissions 
to fewer than 5%. The impact of the North Southwark Community Team 
for Older People, in partnership with OASIS, earned the team a Clinical 
Governance Award in the category of ‘choice and empowerment’ from South 
London and Maudsley NHS Trust in 2006. Engagement of other stakeholders, 
such as the Southwark Irish Pensioners Project, has also resulted in 
increased awareness of alcohol misuse and dual diagnosis in the borough. 
However, the problem of alcohol misuse in the area is still increasing, 
and there has been an 80% increase in the number of older people with dual 
diagnosis on the team case-load between 2003 and 2009. 
As awareness also improved within the addictions directorate of the 
Trust, the provision of level 1 (generic) dual diagnosis training to 15 clinicians 
across a number of disciplines in the Older Adults Directorate took place in 
2009, followed by a training-needs analysis. The existence of generic training 
has provided non-medical clinical staff within the North Southwark team with 
the skills to screen for the presence of coexisting mental health difficulties 
and substance misuse; develop and sustain collaborative therapeutic 
relationships with patients who have a dual diagnosis; systematically assess 
the needs of these patients and construct basic care plans designed to 
address these needs; implement simple, low-intensity, evidence-based dual 
diagnosis interventions safely and effectively in partnership with patients; 
and recognise patients whose needs are sufficiently complex to require high-
intensity dual diagnosis interventions and refer them to specialist services. 
Over the past decade, considerable progress has been made in meeting 
the needs of older people with alcohol misuse and accompanying mental 
disorders such as depression and cognitive impairment. The Trust now has 
its own older adults’ dual diagnosis steering group. It is hoped that continued 
delivery of level 1 training and a further training-needs analysis will equip a 
range of clinicians with the knowledge and skills to be able to manage dual 
diagnosis in older people more effectively and with positive health and social 
outcomes.
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Joint service provision by the aDDictions Directorate 
central & north West lonDon nhs trust anD the olD 
aGe Directorate West lonDon mental health trust 
This model underpins the key message of the Department of Health’s Dual 
Diagnosis – Good Practice Guidance (2002) that comorbidity should be 
‘mainstreamed’. The agreed policy thus explicitly states that services for 
older people with comorbid mental health and alcohol-related problems will 
be delivered by the older peoples’ psychiatric services, supported by the 
local community alcohol service. The model has clearly defined reciprocal 
and complementary referral processes for both services. The following are 
the salient points of the model.
  Screening tools are to be used by older peoples’ services for all 
patients presenting by incorporating screening into their routine 
assessment procedures. The SMAST-G (Blow et al, 1998) will be the 
instrument used for this. Alcohol services would use the MMSE (Folstein 
et al, 1975) in addition to the clinical psychiatric examination to assess 
patients as a routine.
  A simple tool has been introduced to help clinical staff in older peoples’ 
services to determine the extent and context of alcohol consumption 
by patients. 
  Emphasis is placed on knowledge and recognition of the demarcation 
between hazardous, harmful and dependent use of alcohol. 
  Hazardous and harmful alcohol use have linked to them a stepped 
approach for interventions on the brief intervention/motivational 
interviewing model, carried out by older peoples’ services for a 
specified period (8 weeks). Patients who do not respond to this 
are referred to the community alcohol service. Alcohol dependence 
means an automatic referral to the community alcohol service. The 
same principle applies to the alcohol service for patients in their care: 
those who have less severe mental health problems are managed 
by the alcohol team or in primary care. Those with severe mental 
health problems are referred to and treated jointly with older peoples’ 
services.
  At point of referral and subsequently, the model has agreed criteria 
that trigger joint assessments and joint home visits by the two teams. 
This involves assessments by both services in both community and 
in-patient settings. The older peoples’ services will take the lead for 
patients who are subject to the care programme approach (CPA).
There is a need for a clear and systematic plan to develop a training 
package and the protocol does this by paving the way for staff on both teams 
to be allowed to spend time on brief attachment to each other’s service, 
attend multidisciplinary team meetings and receive more formal training 
on core competencies such as screening and identification, motivational 
interviewing and recognising the different levels of severity of alcohol misuse 
and mental health problems. 
Owing to the special needs of this population, the involvement of family 
members and carers is emphasised and the provision of information and 
support to them is included in the protocol. 
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  ‘Alcohol and Older People’: leaflet, podcasts and links to related 
information (http://www.rcpsych.ac.uk/mentalhealthinfo/problems/
alcoholanddrugs/alcoholandolderpeople.aspx)
  ‘Alcohol-related dementia: a 21st-century silent epidemic?’: podcast 
in which Dr Susham Gupta discusses this editorial in the British 
Journal of Psychiatry with Dr Mark Salter (http://www.rcpsych.ac.uk/
pressparliament/podcasts/alcohol-relateddementia.aspx)
  ‘UK heading towards a “silent epidemic” of alcohol-related 
dementia’: press release on Dr Susham Gupta’s editorial in the 
British Journal of Psychiatry, with a link to the editorial (http://
www.rcpsych.ac.uk/pressparliament/pressreleases2008/bank2008/
pralcoholrelateddementia.aspx?theme=print)
  John Wattis (1998) Personality disorders and alcohol dependence. In 
Seminars in Old Age Psychiatry (eds R. Butler & B. Pitt): pp. 163–179. 
Gaskell. PDF of chapter (http://www.rcpsych.ac.uk/pdf/semOAP_ch11.
pdf)
  ‘Significantly more alcohol misuse among mentally ill older men 
in Glasgow than in Dundee’: summary of findings presented by Dr 
C. Rodriguez and colleagues at the Royal College of Psychiatrists’ 
Annual Meeting in 2000 (http://www.rcpsych.ac.uk/pressparliament/
pressreleasearchive/pr98.aspx)
  Minutes of Meeting of the Executive Committee and Regional 
Representatives of the Faculty for the Psychiatry of Old Age, 22 
November 2007 (http://www.rcpsych.ac.uk/docs/2007%2011%20
22%20minutes.doc) 
  Roberts, A. (2002) The older drinker. Old Age Psychiatrist, 28, 10 
(http://www.rcpsych.ac.uk/pdf/OAP28.pdf)
  Hillam, J. (2005) Supporting quality of life. Old Age Psychiatrist, 37, 2 
(http://www.rcpsych.ac.uk/pdf/OAP_371.pdf)
  O’Connell, H. (2005) Alcohol use disorders in older people. Old Age 
Psychiatrist, 37, 3 (http://www.rcpsych.ac.uk/pdf/OAP_371.pdf)
  Royal College of Physicians & Royal College of Psychiatrists (2001) 
Role of Consultants with Responsibility for Substance Misuse (Addiction 
Psychiatrists): Position Statement by the Faculty of Substance Misuse 
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(Council Report CR97). Royal College of Psychiatrists (http://www.
rcpsych.ac.uk/files/pdfversion/cr97.pdf) 
  Royal College of Psychiatrists (2005) Roles and Responsibilities of 
Doctors in the Provision of Treatment for Drug and Alcohol Misusers 
(College Report CR131). Royal College of Psychiatrists (http://www.
rcpsych.ac.uk/files/pdfversion/cr131.pdf)
other sources
  Institute of Alcohol Studies (2010) Alcohol & The Elderly: IAS Factsheet 
(http://www.ias.org.uk/resources/factsheets/elderly.pdf)
  Shaw C. & Palattiyil, G. (2008) Issues of alcohol misuse among older 
people: attitudes and experiences of social work practitioners. Practice, 
20, 181–193 (http://www.informaworld.com/smpp/content~db=all~c
ontent=a902096844~frm=titlelink) 
  University of Brighton (2008) Cheers!? A project about older people 
and alcohol (http://www.brighton.ac.uk/sass/research/publications/
Cheers_Findings.pdf)
  Social Care Institute for Excellence (2006) SCIE Guide 3: Assessing the 
mental health needs of older people. Extended resume of: Herring R & 
Thom B (1997) Alcohol misuse in older people: the role of home carers. 
Health and Social Care in the Community, 5, 237–245. (http://www.
scie.org.uk/publications/guides/guide03/resumes/resume04.asp)
  Social Care Institute for Excellence (2006) SCIE Guide 3: Assessing the 
mental health needs of older people. Extended resume of: Derry A D 
(2000) Substance use in older adults: a review of current assessment, 
treatment and service provision. Journal of Substance Use, 5, 252–
262 (http://www.scie.org.uk/publications/guides/guide03/resumes/
resume02.asp)
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